Palvella Therapeutics announces a new product candidate from its QTORIN program, expanding its portfolio in the pharmaceutical industry.
| Name | PALVELLA THERAPEUTICS, INC. |
|---|---|
| CIK | 0001583648 |
| Tickers | PVLA |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 300784346 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | NV NV |
| Phone | (484) 253-1461 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 1 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Palvella Therapeutics announces a new product candidate from its QTORIN program, expanding its portfolio in the pharmaceutical industry.
Palvella Therapeutics, Inc. shares its Q3 2026 results, outlining developments in its pharmaceutical pipeline and competitive positioning.
Palvella Therapeutics, Inc. announces its financial results for the third quarter of 2026, reflecting ongoing efforts in the pharmaceutical sector.
Palvella Therapeutics announces FDA acceptance of its New Drug Application for QTORIN™, a significant milestone in the pharmaceutical preparations sector.
Palvella Therapeutics, Inc. discloses stock transactions by director George M. Jenkins, highlighting active management in the pharmaceutical preparations sector.
820 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-19 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-26-467823 | 001-37471 | 261572326 | 34 | 8989645 | 1 | 1 |
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001231919-26-001584 | 005-88917 | 261561430 | 34 | 33821 | |||
| 2026-11-12 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-126376 | 41617 | ||||||
| 2026-11-10 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-010958 | 001-37471 | 261540839 | 33 | 5311 | |||
| 2026-11-05 | 10-Q | 10-Q | 0001193125-26-448638 | 001-37471 | 261524891 | 34 | 8415626 | 1 | 1 | |
| 2026-11-05 | 8-K | 8-K | 2.02,7.01,9.01 | 0001193125-26-448594 | 001-37471 | 261524801 | 34 | 10415159 | 1 | 1 |
| 2026-10-28 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000053417-26-000064 | 005-88917 | 261495567 | 34 | 6914 | |||
| 2026-10-28 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-435113 | 001-37471 | 261492441 | 34 | 265697 | 1 | 1 |
| 2026-10-23 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-118466 | 17815 | ||||||
| 2026-10-21 | 144 | xsl144X01/primary_doc.xml | 0001967940-26-000055 | 001-37471 | 261475947 | 33 | 6716 | |||
| 2026-10-14 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-115916 | 39740 | ||||||
| 2026-10-13 | 144 | xsl144X01/primary_doc.xml | 0001967940-26-000053 | 001-37471 | 261457509 | 33 | 6701 | |||
| 2026-09-18 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-108930 | 17822 | ||||||
| 2026-09-16 | 144 | xsl144X01/primary_doc.xml | 0001967940-26-000051 | 001-37471 | 261384144 | 33 | 6751 | |||
| 2026-09-15 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-108022 | 24041 | ||||||
| 2026-09-11 | 144 | xsl144X01/primary_doc.xml | 0001967940-26-000050 | 001-37471 | 261374781 | 33 | 4790 | |||
| 2026-09-04 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-105494 | 9253 | ||||||
| 2026-09-02 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-008991 | 001-37471 | 261354857 | 33 | 5009 | |||
| 2026-08-20 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-099222 | 21370 | ||||||
| 2026-08-19 | 144 | xsl144X01/primary_doc.xml | 0001967940-26-000044 | 001-37471 | 261296123 | 33 | 6715 | |||
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001999371-26-018011 | 005-88917 | 261282705 | 34 | 14483 | |||
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000921895-26-002180 | 005-88917 | 261282060 | 34 | 23640 | |||
| 2026-08-10 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001137774-26-000180 | 005-88917 | 261257790 | 34 | 7959 | |||
| 2026-08-04 | S-8 | FORM S-8 | 0001104659-26-090394 | 333-297957 | 261239037 | 33 | 223749 | 1 | 1 | |
| 2026-08-04 | 10-Q | 10-Q | 0001193125-26-331574 | 001-37471 | 261235537 | 34 | 7687421 | 1 | 1 | |
| 2026-08-04 | 8-K | 8-K | 2.02,7.01,9.01 | 0001193125-26-331556 | 001-37471 | 261235475 | 34 | 12366138 | 1 | 1 |
| 2026-08-03 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000053417-26-000050 | 005-88917 | 261231012 | 34 | 6779 | |||
| 2026-07-29 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0002012383-26-002924 | 005-88917 | 261216983 | 34 | 11291 | |||
| 2026-07-17 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-084620 | 19859 | ||||||
| 2026-07-15 | 144 | xsl144X01/primary_doc.xml | 0001967940-26-000039 | 001-37471 | 261177595 | 33 | 6751 | |||
| 2026-07-14 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-303307 | 001-37471 | 261174776 | 34 | 29318917 | 1 | 1 |
| 2026-07-01 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-079865 | 5873 | ||||||
| 2026-07-01 | 3 | OWNERSHIP DOCUMENT | 0001104659-26-079863 | 8874 | ||||||
| 2026-06-30 | 8-K | FORM 8-K | 5.02 | 0001104659-26-079087 | 001-37471 | 261137995 | 34 | 193331 | 1 | 1 |
| 2026-06-22 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-076460 | 17299 | ||||||
| 2026-06-17 | 144 | xsl144X01/primary_doc.xml | 0001967940-26-000032 | 001-37471 | 261099438 | 33 | 6751 | |||
| 2026-06-16 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-074574 | 7444 | ||||||
| 2026-06-16 | 8-K | FORM 8-K | 5.02,5.07,9.01 | 0001104659-26-074338 | 001-37471 | 261092959 | 34 | 223391 | 1 | 1 |
| 2026-06-12 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-073443 | 6043 | ||||||
| 2026-06-12 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-073442 | 6064 | ||||||
| 2026-06-12 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-073437 | 6021 | ||||||
| 2026-06-12 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-073432 | 6046 | ||||||
| 2026-06-12 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-073426 | 6049 | ||||||
| 2026-06-12 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-073420 | 6062 | ||||||
| 2026-05-22 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-065692 | 17299 | ||||||
| 2026-05-20 | 144 | xsl144X01/primary_doc.xml | 0001967940-26-000016 | 001-37471 | 261005276 | 33 | 6126 | |||
| 2026-05-20 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-232717 | 001-37471 | 261004568 | 34 | 259209 | 1 | 1 |
| 2026-05-15 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-225317 | 001-37471 | 26982251 | 34 | 244854 | 1 | 1 |
| 2026-05-13 | 8-K | 8-K | 8.01 | 0001193125-26-220607 | 001-37471 | 26970934 | 34 | 148326 | 1 | 1 |
| 2026-05-07 | 8-K | 8-K | 2.02,7.01,9.01 | 0001193125-26-210605 | 001-37471 | 26951183 | 34 | 14504783 | 1 | 1 |
| 2026-05-07 | 10-Q | 10-Q | 0001193125-26-210463 | 001-37471 | 26951035 | 34 | 6324772 | 1 | 1 | |
| 2026-04-30 | ARS | ARS | 0001104659-26-052938 | 001-37471 | 26925508 | 34 | 26401492 | |||
| 2026-04-30 | DEFA14A | DEFA14A | 0001104659-26-052923 | 001-37471 | 26925418 | 34 | 481501 | |||
| 2026-04-30 | DEF 14A | DEF 14A | 0001104659-26-052875 | 001-37471 | 26925070 | 34 | 3855640 | 1 | 1 | |
| 2026-04-17 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-044895 | 21372 | ||||||
| 2026-04-15 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-043793 | 5872 | ||||||
| 2026-04-15 | 3 | OWNERSHIP DOCUMENT | 0001104659-26-043788 | 10261 | ||||||
| 2026-04-15 | 144 | xsl144X01/primary_doc.xml | 0001967940-26-000009 | 001-37471 | 26864069 | 33 | 6786 | |||
| 2026-04-13 | 8-K | 8-K | 5.02 | 0001193125-26-151979 | 001-37471 | 26856438 | 34 | 155450 | 1 | 1 |
| 2026-04-07 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-144540 | 001-37471 | 26842912 | 34 | 22766215 | 1 | 1 |
| 2026-04-01 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-038496 | 5887 | ||||||
| 2026-03-31 | 10-K | 10-K | 0001193125-26-133372 | 001-37471 | 26817225 | 34 | 18500053 | 1 | 1 | |
| 2026-03-31 | 8-K | 8-K | 2.02,7.01,9.01 | 0001193125-26-133332 | 001-37471 | 26817102 | 34 | 11304524 | 1 | 1 |
| 2026-03-20 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-032695 | 17752 | ||||||
| 2026-03-18 | 144 | xsl144X01/primary_doc.xml | 0001967940-26-000008 | 001-37471 | 26768665 | 33 | 6493 | |||
| 2026-03-02 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-021922 | 5988 | ||||||
| 2026-03-02 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-021921 | 5824 | ||||||
| 2026-02-26 | 8-K | FORM 8-K | 1.01,9.01 | 0001104659-26-020667 | 001-37471 | 26690697 | 34 | 584662 | 1 | 1 |
| 2026-02-26 | 424B5 | 424B5 | 0001104659-26-020659 | 333-292544 | 26690682 | 33 | 749795 | |||
| 2026-02-24 | 424B5 | 424B5 | 0001104659-26-019152 | 333-292544 | 26672052 | 33 | 790600 | |||
| 2026-02-24 | 8-K | FORM 8-K | 2.02 | 0001104659-26-019143 | 001-37471 | 26671945 | 34 | 189605 | 1 | 1 |
| 2026-02-24 | 8-K | 8-K | 7.01,9.01 | 0001193125-26-065308 | 001-37471 | 26667583 | 34 | 12204270 | 1 | 1 |
| 2026-02-24 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-065159 | 001-37471 | 26667383 | 34 | 1330419 | 1 | 1 |
| 2026-02-20 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-018136 | 15643 | ||||||
| 2026-02-19 | 144/A | xsl144X01/primary_doc.xml | 0001967940-26-000005 | 001-37471 | 26655853 | 33 | 6793 | |||
| 2026-02-18 | 144 | xsl144X01/primary_doc.xml | 0001967940-26-000004 | 001-37471 | 26648036 | 33 | 6490 | |||
| 2026-02-17 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001999371-26-003517 | 005-88917 | 26642412 | 34 | 14525 | |||
| 2026-02-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000921895-26-000471 | 005-88917 | 26641812 | 34 | 24177 | |||
| 2026-02-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001231919-26-000151 | 005-88917 | 26634860 | 34 | 44342 | |||
| 2026-02-09 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-012068 | 5881 | ||||||
| 2026-02-09 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-012067 | 5904 | ||||||
| 2026-02-09 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-012066 | 5867 | ||||||
| 2026-02-09 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-012064 | 5872 | ||||||
| 2026-02-09 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-012060 | 5872 | ||||||
| 2026-01-29 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-000347 | 333-292544 | 26580311 | 33 | 2063 | ||
| 2026-01-29 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-029341 | 001-37471 | 26577972 | 34 | 26471144 | 1 | 1 |
| 2026-01-27 | CORRESP | filename1.htm | 0001104659-26-006806 | 7686 | ||||||
| 2026-01-23 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-006237 | 14605 | ||||||
| 2026-01-21 | 144 | xsl144X01/primary_doc.xml | 0001967940-26-000002 | 001-37471 | 26548328 | 33 | 6133 | |||
| 2026-01-12 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-009724 | 001-37471 | 26524619 | 34 | 26528147 | 1 | 1 |
| 2026-01-05 | UPLOAD | filename1.pdf | 0000000000-26-000081 | 333-292544 | 40418 | |||||
| 2026-01-02 | S-3 | S-3 | 0001104659-26-000065 | 333-292544 | 26500216 | 33 | 1036464 | 1 | 1 | |
| 2025-12-19 | 4 | OWNERSHIP DOCUMENT | 0001104659-25-123109 | 13591 | ||||||
| 2025-12-17 | 144 | xsl144X01/primary_doc.xml | 0001967940-25-000095 | 001-37471 | 251579754 | 33 | 5469 | |||
| 2025-12-15 | 8-K | FORM 8-K | 7.01,8.01,9.01 | 0001104659-25-120789 | 001-37471 | 251569906 | 34 | 2697336 | 1 | 1 |
| 2025-11-21 | 4 | OWNERSHIP DOCUMENT | 0001104659-25-115017 | 15144 | ||||||
| 2025-11-19 | 144 | xsl144X01/primary_doc.xml | 0001967940-25-000085 | 001-37471 | 251499922 | 33 | 4804 | |||
| 2025-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000921895-25-003114 | 005-88917 | 251486671 | 34 | 25622 | |||
| 2025-11-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000919574-25-006758 | 005-88917 | 251479935 | 34 | 17220 | |||
| 2025-11-12 | 10-Q | 10-Q | 0001193125-25-276119 | 001-37471 | 251469343 | 34 | 7784800 | 1 | 1 | |
| 2025-11-10 | 8-K | 8-K | 2.02,7.01,9.01 | 0001193125-25-274378 | 001-37471 | 251466714 | 34 | 9394739 | 1 | 1 |
| 2025-11-05 | 8-K | FORM 8-K | 7.01,8.01,9.01 | 0001104659-25-106591 | 001-37471 | 251451599 | 34 | 4853553 | 1 | 1 |
| 2025-09-24 | 8-K | FORM 8-K | 7.01,9.01 | 0001104659-25-092681 | 001-37471 | 251335117 | 34 | 257279 | 1 | 1 |
| 2025-09-03 | 8-K | 8-K | 7.01,9.01 | 0001104659-25-086685 | 001-37471 | 251287755 | 34 | 12445235 | 1 | 1 |
| 2025-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001415889-25-021969 | 005-88917 | 251221195 | 34 | 12050 | |||
| 2025-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001415889-25-021793 | 005-88917 | 251217130 | 34 | 44022 | |||
| 2025-08-14 | 10-Q | 10-Q | 0000950170-25-108438 | 001-37471 | 251214422 | 34 | 7503102 | 1 | 1 | |
| 2025-08-14 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-25-108422 | 001-37471 | 251214346 | 34 | 6041862 | 1 | 1 |
| 2025-06-11 | 4 | PRIMARY DOCUMENT | 0001583648-25-000042 | 5352 | ||||||
| 2025-06-11 | 4 | PRIMARY DOCUMENT | 0001583648-25-000041 | 5231 | ||||||
| 2025-06-11 | 4 | PRIMARY DOCUMENT | 0001583648-25-000040 | 5357 | ||||||
| 2025-06-11 | 4 | PRIMARY DOCUMENT | 0001583648-25-000039 | 5312 | ||||||
| 2025-06-11 | 4 | PRIMARY DOCUMENT | 0001583648-25-000038 | 5338 | ||||||
| 2025-06-11 | 8-K | FORM 8-K | 5.07 | 0001104659-25-058532 | 001-37471 | 251039961 | 34 | 197536 | 1 | 1 |
| 2025-06-03 | 4 | PRIMARY DOCUMENT | 0001583648-25-000030 | 7746 | ||||||
| 2025-06-03 | 3 | PRIMARY DOCUMENT | 0001583648-25-000029 | 6030 | ||||||
| 2025-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001415889-25-012986 | 005-88917 | 25949383 | 34 | 57750 | |||
| 2025-05-15 | 10-Q | 10-Q | 0000950170-25-071998 | 001-37471 | 25948752 | 34 | 6640117 | 1 | 1 | |
| 2025-05-15 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-25-071988 | 001-37471 | 25948720 | 34 | 8151575 | 1 | 1 |
| 2025-04-30 | ARS | ARS | 0001104659-25-042518 | 001-37471 | 25895331 | 34 | 2253996 | |||
| 2025-04-30 | DEFA14A | DEFA14A | 0001104659-25-042506 | 001-37471 | 25895076 | 34 | 425565 | |||
| 2025-04-30 | DEF 14A | FORM DEF 14A | 0001104659-25-042493 | 001-37471 | 25894961 | 34 | 3662108 | 1 | 1 | |
| 2025-04-10 | 4 | PRIMARY DOCUMENT | 0001583648-25-000025 | 6330 | ||||||
| 2025-03-31 | 10-K | 10-K | 0000950170-25-047212 | 001-37471 | 25788958 | 34 | 16757349 | 1 | 1 | |
| 2025-03-31 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-25-047206 | 001-37471 | 25788921 | 34 | 12924153 | 1 | 1 |
| 2025-03-04 | 8-K | FORM 8-K | 7.01,9.01 | 0001437749-25-006013 | 001-37471 | 25701603 | 34 | 7606534 | 1 | 1 |
| 2025-02-18 | S-8 | FORM S-8 | 0001437749-25-004229 | 333-285029 | 25635674 | 33 | 169228 | |||
| 2025-02-10 | 4/A | PRIMARY DOCUMENT | 0001583648-25-000023 | 5779 | ||||||
| 2025-02-10 | 4/A | PRIMARY DOCUMENT | 0001583648-25-000021 | 7826 | ||||||
| 2025-02-10 | 4/A | PRIMARY DOCUMENT | 0001583648-25-000019 | 7807 | ||||||
| 2025-02-10 | 4/A | PRIMARY DOCUMENT | 0001583648-25-000017 | 7824 | ||||||
| 2025-02-07 | 4 | PRIMARY DOCUMENT | 0001583648-25-000015 | 001-37471 | 25602328 | 34 | 8180 | |||
| 2025-02-07 | 4 | PRIMARY DOCUMENT | 0001583648-25-000014 | 001-37471 | 25602298 | 34 | 8175 | |||
| 2025-02-07 | 4 | PRIMARY DOCUMENT | 0001583648-25-000013 | 001-37471 | 25602256 | 34 | 6149 | |||
| 2025-02-07 | 4 | PRIMARY DOCUMENT | 0001583648-25-000012 | 001-37471 | 25602250 | 34 | 8174 | |||
| 2025-01-17 | 424B3 | FORM 424B3 | 0001437749-25-001381 | 333-284093 | 25538735 | 33 | 5645984 | |||
| 2025-01-16 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-000134 | 333-284093 | 25536871 | 33 | 2058 | ||
| 2025-01-15 | CORRESP | filename1.htm | 0001437749-25-001170 | 12809 | ||||||
| 2025-01-14 | S-1/A | FORM S-1/A | 0001437749-25-001017 | 333-284093 | 25527680 | 33 | 15232206 | 1 | 1 | |
| 2025-01-13 | 8-K | FORM 8-K | 7.01,9.01 | 0001437749-25-000924 | 001-37471 | 25524732 | 34 | 9797515 | 1 | 1 |
| 2025-01-08 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001415889-25-001108 | 005-88917 | 25518214 | 34 | 56380 | |||
| 2025-01-06 | 3/A | AMENDED INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-25-000400 | 485798 | ||||||
| 2025-01-03 | UPLOAD | filename1.pdf | 0000000000-25-000059 | 333-284093 | 40463 | |||||
| 2024-12-31 | S-1 | FORM S-1 | 0001437749-24-038553 | 333-284093 | 241591074 | 33 | 25650195 | 1 | 1 | |
| 2024-12-20 | SCHEDULE 13D | xslSCHEDULE_13D_X01/primary_doc.xml | 0001437749-24-038167 | 005-88917 | 241569090 | 34 | 39190 | |||
| 2024-12-20 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001415889-24-029979 | 005-88917 | 241568725 | 34 | 14424 | |||
| 2024-12-20 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000919574-24-007251 | 005-88917 | 241568701 | 34 | 16939 | |||
| 2024-12-19 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-020879 | 6010 | ||||||
| 2024-12-17 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-020823 | 5481 | ||||||
| 2024-12-17 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-020822 | 5521 | ||||||
| 2024-12-17 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-020821 | 5509 | ||||||
| 2024-12-17 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-020820 | 5528 | ||||||
| 2024-12-17 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-020819 | 5516 | ||||||
| 2024-12-17 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-020818 | 5596 | ||||||
| 2024-12-17 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-020817 | 5524 | ||||||
| 2024-12-17 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-020816 | 5511 | ||||||
| 2024-12-17 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-020815 | 502498 | ||||||
| 2024-12-17 | 4 | OWNERSHIP DOCUMENT | 0000921895-24-002972 | 51500 | ||||||
| 2024-12-17 | SC 13G/A | AMENDMENT NO. 1 TO SCHEDULE 13G | 0000921895-24-002971 | 005-88917 | 241556953 | 34 | 284392 | |||
| 2024-12-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001943462-24-000010 | 005-88917 | 241555964 | 34 | 76469 | |||
| 2024-12-16 | 3 | INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-020699 | 515939 | ||||||
| 2024-12-16 | 3 | INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-020698 | 505395 | ||||||
| 2024-12-16 | 3 | INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-020697 | 489403 | ||||||
| 2024-12-16 | 3 | INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-020696 | 1098456 | ||||||
| 2024-12-16 | 3 | INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-020695 | 1109962 | ||||||
| 2024-12-16 | 3 | INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-020694 | 1093811 | ||||||
| 2024-12-16 | 3 | INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-020693 | 1088939 | ||||||
| 2024-12-16 | 3 | INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-020692 | 447484 | ||||||
| 2024-12-16 | 4 | PRIMARY DOCUMENT | 0001943462-24-000008 | 3986 | ||||||
| 2024-12-16 | 8-K | FORM 8-K | 1.01,2.01,3.02,3.03,5.01,5.02,5.03,5.05,5.06,8.01,9.01 | 0001437749-24-037515 | 001-37471 | 241549973 | 34 | 9122597 | 1 | 1 |
| 2024-12-12 | 4 | FORM 4 (GERAGHTY SERIES F) | 0001437749-24-037353 | 4875 | ||||||
| 2024-12-12 | 425 | FORM 425 | 0001437749-24-037352 | 001-37471 | 241545000 | 34 | 1467781 | |||
| 2024-12-12 | 8-K | FORM 8-K | 3.03,5.02,5.03,5.07,8.01,9.01 | 0001437749-24-037350 | 001-37471 | 241544971 | 34 | 1640425 | 1 | 1 |
| 2024-12-09 | 4 | FORM 4 (ANNUAL GRANT) | 0001437749-24-036916 | 5071 | ||||||
| 2024-12-06 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001943462-24-000007 | 005-88917 | 241531836 | 34 | 76974 | |||
| 2024-12-03 | 425 | FORM 425 | 0001437749-24-036507 | 001-37471 | 241521248 | 34 | 68382 | |||
| 2024-12-03 | 8-K | FORM 8-K | 5.07,8.01,9.01 | 0001437749-24-036506 | 001-37471 | 241521246 | 34 | 217131 | 1 | 1 |
| 2024-11-18 | 3 | PRIMARY DOCUMENT | 0001943462-24-000005 | 4883 | ||||||
| 2024-11-14 | SC 13G/A | PIERIS PHARMACEUTICALS, INC. | 0000902664-24-006519 | 005-88917 | 241457639 | 34 | 66871 | |||
| 2024-11-13 | 10-Q | FORM 10-Q | 0001437749-24-034891 | 001-37471 | 241453901 | 34 | 5138303 | 1 | 1 | |
| 2024-11-12 | SEC STAFF LETTER | filename1.pdf | 9999999997-24-004381 | 64320 | ||||||
| 2024-11-08 | EFFECT | xslEFFECTX01/primary_doc.xml | S-4,,2024-11-08 17:00:00 | 9999999995-24-003418 | 333-281459 | 241442670 | 33 | 1857 | ||
| 2024-11-08 | 424B3 | FORM 424B3 | 0001437749-24-034238 | 333-281459 | 241441780 | 33 | 11820517 | |||
| 2024-11-07 | 425 | FORM 425 | 0001437749-24-033781 | 001-37471 | 241433435 | 34 | 27748 | |||
| 2024-11-07 | CORRESP | filename1.htm | 0001437749-24-033779 | 13616 | ||||||
| 2024-11-07 | S-4/A | FORM S-4/A | 0001437749-24-033778 | 333-281459 | 241433401 | 33 | 12046131 | |||
| 2024-11-06 | DEF 14A | FORM DEF 14A | 0001437749-24-033669 | 001-37471 | 241432015 | 34 | 1526880 | |||
| 2024-11-06 | ARS | FORM ARS | 0001437749-24-033668 | 001-37471 | 241431995 | 34 | 1341524 | |||
| 2024-11-05 | CORRESP | filename1.htm | 0001437749-24-033378 | 20013 | ||||||
| 2024-11-05 | S-4/A | FORM S-4/A | 0001437749-24-033377 | 333-281459 | 241428413 | 33 | 12048171 | |||
| 2024-11-04 | UPLOAD | filename1.pdf | 0000000000-24-012240 | 333-281459 | 44228 | |||||
| 2024-10-29 | CORRESP | filename1.htm | 0001437749-24-032371 | 43400 | ||||||
| 2024-10-29 | S-4/A | FORM S-4/A | 0001437749-24-032370 | 333-281459 | 241402797 | 33 | 13351300 | |||
| 2024-10-28 | 4 | FORM 4 (SERIES F) | 0001437749-24-032319 | 5219 | ||||||
| 2024-10-25 | SEC STAFF LETTER | filename1.pdf | 9999999997-24-004216 | 65350 | ||||||
| 2024-10-25 | UPLOAD | filename1.pdf | 0000000000-24-011959 | 333-281459 | 55893 | |||||
| 2024-10-17 | 425 | FORM 425 | 0001437749-24-031428 | 001-37471 | 241375941 | 34 | 30715 | |||
| 2024-10-15 | CORRESP | filename1.htm | 0001437749-24-031190 | 43422 | ||||||
| 2024-10-15 | S-4/A | FORM S-4/A | 0001437749-24-031189 | 333-281459 | 241369441 | 33 | 12530736 | |||
| 2024-10-15 | 425 | FORM 425 | 0001437749-24-031186 | 001-37471 | 241369351 | 34 | 30284 | |||
| 2024-10-09 | UPLOAD | filename1.pdf | 0000000000-24-011415 | 333-281459 | 58476 | |||||
| 2024-10-03 | 425 | FORM 425 | 0001437749-24-030560 | 001-37471 | 241349930 | 34 | 53999 | |||
| 2024-10-03 | 8-K | FORM 8-K | 8.01,9.01 | 0001437749-24-030559 | 001-37471 | 241349926 | 34 | 198983 | 1 | 1 |
| 2024-09-23 | CORRESP | filename1.htm | 0001437749-24-029799 | 117381 | ||||||
| 2024-09-23 | S-4/A | FORM S-4/A | 0001437749-24-029789 | 333-281459 | 241314568 | 33 | 11957764 | |||
| 2024-09-06 | UPLOAD | filename1.pdf | 0000000000-24-010139 | 333-281459 | 103458 | |||||
| 2024-08-14 | 10-Q | FORM 10-Q | 0001437749-24-026778 | 001-37471 | 241207294 | 34 | 5490349 | 1 | 1 | |
| 2024-08-12 | 4 | PRIMARY DOCUMENT | 0001940272-24-000006 | 11481 | ||||||
| 2024-08-09 | S-4 | FORM S-4 | 0001437749-24-025929 | 333-281459 | 241194153 | 33 | 12494789 | |||
| 2024-08-08 | 425 | FORM 425 | 0001437749-24-025566 | 001-37471 | 241188664 | 34 | 1602063 | |||
| 2024-08-08 | 8-K | FORM 8-K | 1.01,3.02,3.03,5.03,9.01 | 0001437749-24-025565 | 001-37471 | 241188653 | 34 | 1757126 | 1 | 1 |
| 2024-08-07 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001943462-24-000004 | 005-88917 | 241182943 | 34 | 15729 | |||
| 2024-08-01 | SC 13G | SC 13G | 0001104659-24-084642 | 005-88917 | 241164413 | 34 | 85249 | |||
| 2024-07-31 | 3 | PRIMARY DOCUMENT | 0001758866-24-000005 | 7934 | ||||||
| 2024-07-24 | 425 | FORM 425 | 0001437749-24-023302 | 001-37471 | 241136059 | 34 | 6735767 | |||
| 2024-07-24 | 8-K | FORM 8-K | 1.01,3.02,5.02,8.01,9.01 | 0001437749-24-023301 | 001-37471 | 241136057 | 34 | 7265388 | 1 | 1 |
| 2024-07-03 | 8-K | FORM 8-K | 1.02,8.01,9.01 | 0001437749-24-022188 | 001-37471 | 241100541 | 34 | 171332 | 1 | 1 |
| 2024-05-17 | SC 13G | THE SCHEDULE 13G | 0000921895-24-001271 | 005-88917 | 24961207 | 34 | 294934 | |||
| 2024-05-17 | SC 13G | THE SCHEDULE 13G | 0000921895-24-001270 | 005-88917 | 24961202 | 34 | 294934 | |||
| 2024-05-15 | 10-Q | FORM 10-Q | 0001437749-24-017037 | 001-37471 | 24950163 | 34 | 5333556 | 1 | 1 | |
| 2024-05-09 | 8-K | FORM 8-K | 8.01 | 0001437749-24-015466 | 001-37471 | 24928663 | 34 | 160394 | 1 | 1 |
| 2024-04-29 | 10-K/A | FORM 10-K/A | 0001437749-24-013736 | 001-37471 | 24892177 | 34 | 805032 | 1 | 1 | |
| 2024-04-18 | 8-K | FORM 8-K | 3.03,5.03,7.01,9.01 | 0001437749-24-012442 | 001-37471 | 24854561 | 34 | 681804 | 1 | 1 |
| 2024-03-29 | 10-K | FORM 10-K | 0001437749-24-010123 | 001-37471 | 24804919 | 34 | 8087118 | 1 | 1 | |
| 2024-03-27 | 8-K | FORM 8-K | 2.02,8.01,9.01 | 0001437749-24-009491 | 001-37471 | 24785835 | 34 | 202263 | 1 | 1 |
| 2024-02-14 | SC 13G/A | pirs_13gv3.htm | 0001591986-24-000003 | 005-88917 | 24639395 | 34 | 83651 | |||
| 2024-02-14 | SC 13G/A | pirs_13gv3.htm | 0001977548-24-000005 | 005-88917 | 24635368 | 34 | 79927 | |||
| 2024-02-14 | SC 13G/A | PIERIS PHARMACEUTICALS, INC. | 0000902664-24-001607 | 005-88917 | 24633026 | 34 | 64945 | |||
| 2024-02-02 | SC 13G/A | AMENDMENT NO. 2 TO SCHEDULE 13G | 0001213900-24-009385 | 005-88917 | 24589098 | 34 | 105363 | |||
| 2023-12-21 | 8-K | FORM 8-K | 1.02,9.01 | 0001437749-23-035107 | 001-37471 | 231505706 | 34 | 165810 | 1 | 1 |
| 2023-11-14 | 10-Q | FORM 10-Q | 0001437749-23-031957 | 001-37471 | 231405684 | 34 | 5532222 | 1 | 1 | |
| 2023-08-31 | 8-K/A | FORM 8-K/A | 2.05,9.01 | 0001437749-23-024952 | 001-37471 | 231229220 | 34 | 169024 | 1 | 1 |
| 2023-08-17 | SC 13D/A | AMENDMENT NO. 1 TO THE SCHEDULE 13D | 0000921895-23-001997 | 005-88917 | 231182641 | 34 | 290441 | |||
| 2023-08-10 | S-8 | S-8 | 0001193125-23-209166 | 333-273893 | 231160532 | 33 | 101545 | |||
| 2023-08-10 | 10-Q | FORM 10-Q | 0001437749-23-023085 | 001-37471 | 231159924 | 34 | 5562745 | 1 | 1 | |
| 2023-07-18 | 8-K | FORM 8-K | 1.02,2.02,2.05,8.01,9.01 | 0001437749-23-020094 | 001-37471 | 231093137 | 34 | 200908 | 1 | 1 |
| 2023-07-13 | 8-K | FORM 8-K | 5.02,9.01 | 0001437749-23-019831 | 001-37471 | 231085736 | 34 | 162806 | 1 | 1 |
| 2023-06-26 | 8-K | FORM 8-K | 5.02,5.07,9.01 | 0001437749-23-018518 | 001-37471 | 231043309 | 34 | 423176 | 1 | 1 |
| 2023-06-23 | 4 | FORM 4 | 0001437749-23-018284 | 5142 | ||||||
| 2023-06-23 | 4 | FORM 4 | 0001437749-23-018283 | 5152 | ||||||
| 2023-06-23 | 4 | FORM 4 | 0001437749-23-018282 | 5098 | ||||||
| 2023-06-23 | 4 | FORM 4 | 0001437749-23-018281 | 5020 | ||||||
| 2023-06-23 | 4 | FORM 4 | 0001437749-23-018280 | 5114 | ||||||
| 2023-06-23 | 4 | FORM 4 | 0001437749-23-018279 | 5152 | ||||||
| 2023-06-23 | 4 | FORM 4 | 0001437749-23-018278 | 5155 | ||||||
| 2023-06-21 | 8-K | FORM 8-K | 2.02,8.01,9.01 | 0001437749-23-017908 | 001-37471 | 231027385 | 34 | 184029 | 1 | 1 |
| 2023-06-12 | SC 13G | pirsv3_13g.htm | 0001977548-23-000002 | 005-88917 | 231006545 | 34 | 93310 | |||
| 2023-06-08 | 8-K | FORM 8-K | 7.01,9.01 | 0001437749-23-016922 | 001-37471 | 231000582 | 34 | 3259719 | 1 | 1 |
| 2023-05-30 | 4 | PRIMARY DOCUMENT | 0001562180-23-004575 | 4609 | ||||||
| 2023-05-22 | 3 | OWNERSHIP DOCUMENT | 0000921895-23-001312 | 48785 | ||||||
| 2023-05-22 | SC 13D | SCHEDULE 13D | 0000921895-23-001309 | 005-88917 | 23945218 | 34 | 335177 | |||
| 2023-05-19 | 8-K | 8-K | 3.01 | 0001193125-23-149296 | 001-37471 | 23940030 | 34 | 146616 | 1 | 1 |
| 2023-05-11 | 10-Q | FORM 10-Q | 0001437749-23-013687 | 001-37471 | 23908086 | 34 | 5133388 | 1 | 1 | |
| 2023-05-10 | 8-K | FORM 8-K | 2.02,7.01,9.01 | 0001437749-23-013408 | 001-37471 | 23904340 | 34 | 3804142 | 1 | 1 |
| 2023-04-28 | ARS | formars2.pdf | 0001437749-23-011632 | 001-37471 | 23866505 | 34 | 3948230 | |||
| 2023-04-28 | DEFA14A | FORM DEFA14A | 0001437749-23-011631 | 001-37471 | 23866445 | 34 | 448187 | |||
| 2023-04-28 | DEF 14A | FORM DEF 14A | 0001437749-23-011629 | 001-37471 | 23866386 | 34 | 1339040 | |||
| 2023-03-31 | 10-K | FORM 10-K | 0001437749-23-008834 | 001-37471 | 23787391 | 34 | 10175167 | 1 | 1 | |
| 2023-03-29 | 8-K | FORM 8-K | 2.02,7.01,9.01 | 0001437749-23-008303 | 001-37471 | 23771764 | 34 | 7363344 | 1 | 1 |
| 2023-02-28 | 4 | 230228 FORM 4 (BURES) | 0001437749-23-004963 | 5163 | ||||||
| 2023-02-28 | 4 | 230228 FORM 4 (KAUFMANN) | 0001437749-23-004958 | 5171 | ||||||
| 2023-02-28 | 4 | 230228 FORM 4 (MOUSA) | 0001437749-23-004953 | 5142 | ||||||
| 2023-02-28 | 4 | 230228 FORM 4 (OLWILL) | 0001437749-23-004948 | 5166 | ||||||
| 2023-02-28 | 4 | 230228 FORM 4 (YODER) | 0001437749-23-004940 | 5222 | ||||||
| 2023-02-14 | SC 13G/A | PIERIS PHARMACEUTICALS, INC. | 0000902664-23-001799 | 005-88917 | 23628908 | 34 | 66198 | |||
| 2023-02-14 | SC 13G/A | pirs_13gv4.htm | 0001591986-23-000004 | 005-88917 | 23624778 | 34 | 80870 | |||
| 2023-02-14 | SC 13G/A | AMENDMENT NO. 9 TO THE SCHEDULE 13G | 0000921895-23-000484 | 005-88917 | 23621319 | 34 | 287479 | |||
| 2023-02-10 | SC 13G/A | SC 13G/A | 0001193125-23-032632 | 005-88917 | 23612223 | 34 | 43460 | |||
| 2023-02-10 | SC 13G/A | SC 13G/A | 0001104659-23-018079 | 005-88917 | 23609131 | 34 | 56093 | |||
| 2023-01-27 | SC 13G | SC 13G | 0001193125-23-017729 | 005-88917 | 23564074 | 34 | 101941 | |||
| 2023-01-26 | SC 13G/A | SC 13G/A | 0001193125-23-016327 | 005-88917 | 23558488 | 34 | 92743 | |||
| 2023-01-10 | 8-K | FORM 8-K | 7.01,9.01 | 0001437749-23-000801 | 001-37471 | 23521494 | 34 | 178132 | 1 | 1 |
| 2023-01-03 | CT ORDER | filename1.pdf | 20221221,20230103 | 9999999997-22-005020 | 001-37471 | 221478558 | 34 | 164380 | ||
| 2023-01-03 | CT ORDER | filename1.pdf | 20221221,20230103 | 9999999997-22-005017 | 001-37471 | 221478191 | 34 | 161651 | ||
| 2023-01-03 | CT ORDER | filename1.pdf | 20221221,20230103 | 9999999997-22-005015 | 001-37471 | 221478186 | 34 | 161236 | ||
| 2022-12-16 | CT ORDER | filename1.pdf | 20221216,20221216 | 9999999997-22-005007 | 001-37471 | 221466973 | 34 | 160806 | ||
| 2022-11-04 | 424B5 | 424B5 | 0001193125-22-278012 | 333-258497 | 221363041 | 33 | 441046 | |||
| 2022-11-04 | 8-K | FORM 8-K | 1.01,9.01 | 0001437749-22-026051 | 001-37471 | 221362704 | 34 | 226149 | 1 | 1 |
| 2022-11-04 | 10-Q | FORM 10-Q | 0001437749-22-026023 | 001-37471 | 221362247 | 34 | 5868895 | 1 | 1 | |
| 2022-11-02 | 8-K | FORM 8-K | 2.02,7.01,9.01 | 0001437749-22-025458 | 001-37471 | 221352317 | 34 | 8092635 | 1 | 1 |
| 2022-11-01 | 8-K | FORM 8-K | 7.01,9.01 | 0001437749-22-025278 | 001-37471 | 221348714 | 34 | 178272 | 1 | 1 |
| 2022-10-24 | SC 13G | PIERIS PHARMACEUTICALS, INC. | 0000902664-22-004631 | 005-88917 | 221326466 | 34 | 68341 | |||
| 2022-09-13 | 8-K | 8-K | 7.01,9.01 | 0001583648-22-000067 | 001-37471 | 221239775 | 34 | 4416227 | 1 | 1 |
| 2022-08-04 | S-8 | S-8 | 0001193125-22-212640 | 333-266539 | 221137619 | 33 | 86728 | |||
| 2022-08-04 | 10-Q | 10-Q | 0001583648-22-000065 | 001-37471 | 221136938 | 34 | 7072549 | 1 | 1 | |
| 2022-08-04 | 8-K | 8-K | 5.02,9.01 | 0001583648-22-000061 | 001-37471 | 221134905 | 34 | 173902 | 1 | 1 |
| 2022-08-04 | 8-K | 8-K | 2.02,7.01,9.01 | 0001583648-22-000059 | 001-37471 | 221134655 | 34 | 4169033 | 1 | 1 |
| 2022-07-06 | 10-K/A | 10-K/A | 0001583648-22-000057 | 001-37471 | 221069791 | 34 | 539338 | 1 | 1 | |
| 2022-06-27 | 8-K | 8-K | 5.02,5.07,9.01 | 0001583648-22-000055 | 001-37471 | 221041330 | 34 | 361703 | 1 | 1 |
| 2022-06-24 | 4 | FORM 4 | 0001583648-22-000054 | 296246 | ||||||
| 2022-06-24 | 4 | FORM 4 | 0001583648-22-000053 | 5420 | ||||||
| 2022-06-24 | 4 | FORM 4 | 0001583648-22-000052 | 296676 | ||||||
| 2022-06-24 | 4 | FORM 4 | 0001583648-22-000051 | 296150 | ||||||
| 2022-06-24 | 4 | FORM 4 | 0001583648-22-000050 | 294711 | ||||||
| 2022-06-24 | 4 | FORM 4 | 0001583648-22-000049 | 295003 | ||||||
| 2022-06-24 | 4 | FORM 4 | 0001583648-22-000048 | 5423 | ||||||
| 2022-06-08 | 8-K | 8-K | 7.01,9.01 | 0001583648-22-000034 | 001-37471 | 221002600 | 34 | 4314824 | 1 | 1 |
| 2022-05-25 | 8-K | 8-K | 7.01,9.01 | 0001583648-22-000032 | 001-37471 | 22958900 | 34 | 3939958 | 1 | 1 |
| 2022-05-16 | 4 | FORM 4 | 0001583648-22-000030 | 4793 | ||||||
| 2022-05-12 | 8-K/A | 8-K/A | 7.01,9.01 | 0001583648-22-000027 | 001-37471 | 22914946 | 34 | 9752599 | 1 | 1 |
| 2022-05-11 | 10-Q | 10-Q | 0001583648-22-000025 | 001-37471 | 22914318 | 34 | 14451112 | 1 | 1 | |
| 2022-05-11 | 8-K | 8-K | 2.02,7.01,9.01 | 0001583648-22-000023 | 001-37471 | 22912101 | 34 | 9966354 | 1 | 1 |
| 2022-04-29 | DEFA14A | DEFA14A | 0001583648-22-000020 | 001-37471 | 22875375 | 34 | 1179969 | |||
| 2022-04-29 | DEF 14A | DEF 14A | 0001583648-22-000019 | 001-37471 | 22875206 | 34 | 1689539 | |||
| 2022-03-02 | 10-K | 10-K | 0001583648-22-000016 | 001-37471 | 22700659 | 34 | 13253457 | 1 | 1 | |
| 2022-03-01 | 8-K | 8-K | 2.02,7.01,9.01 | 0001583648-22-000012 | 001-37471 | 22693931 | 34 | 9951003 | 1 | 1 |
| 2022-02-24 | 4 | PRIMARY DOCUMENT | 0001562180-22-001876 | 8901 | ||||||
| 2022-02-24 | 4 | PRIMARY DOCUMENT | 0001562180-22-001874 | 8905 | ||||||
| 2022-02-24 | 4 | PRIMARY DOCUMENT | 0001562180-22-001873 | 8915 | ||||||
| 2022-02-24 | 4 | PRIMARY DOCUMENT | 0001562180-22-001872 | 8907 | ||||||
| 2022-02-24 | 4 | PRIMARY DOCUMENT | 0001562180-22-001871 | 8927 | ||||||
| 2022-02-24 | 4 | PRIMARY DOCUMENT | 0001562180-22-001870 | 8929 | ||||||
| 2022-02-14 | SC 13G/A | pirs_13gv1.htm | 0001591986-22-000007 | 005-88917 | 22630394 | 34 | 80518 | |||
| 2022-02-14 | SC 13G/A | AMENDMENT NO. 8 TO THE SCHEDULE 13G | 0000921895-22-000539 | 005-88917 | 22629177 | 34 | 305270 | |||
| 2022-02-14 | SC 13G/A | PIERIS PHARMACEUTICALS, INC. | 0001104659-22-021293 | 005-88917 | 22624749 | 34 | 140127 | |||
| 2022-02-14 | SC 13G/A | AMENDMENT NO.1 TO SCHEDULE 13G | 0001213900-22-007167 | 005-88917 | 22624495 | 34 | 144418 | |||
| 2022-01-27 | SC 13G | SC 13G | 0001193125-22-019851 | 005-88917 | 22563584 | 34 | 103519 | |||
| 2022-01-24 | 8-K | 8-K | 2.02,7.01,9.01 | 0001583648-22-000010 | 001-37471 | 22547561 | 34 | 9269416 | 1 | 1 |
| 2022-01-14 | 8-K | 8-K | 7.01,9.01 | 0001583648-22-000007 | 001-37471 | 22530476 | 34 | 204425 | 1 | 1 |
| 2022-01-14 | 8-K/A | 8-K/A | 7.01,9.01 | 0001583648-22-000006 | 001-37471 | 22530474 | 34 | 175214 | 1 | 1 |
| 2022-01-03 | 8-K | 8-K | 8.01,9.01 | 0001583648-22-000002 | 001-37471 | 22500378 | 34 | 204859 | 1 | 1 |
| 2021-11-18 | 8-K | 8-K | 7.01,9.01 | 0001583648-21-000051 | 001-37471 | 211422625 | 34 | 8795032 | ||
| 2021-11-02 | 10-Q | 10-Q | 0001583648-21-000047 | 001-37471 | 211371330 | 34 | 17870005 | 1 | 1 | |
| 2021-11-02 | 8-K | 8-K | 2.02,9.01 | 0001583648-21-000044 | 001-37471 | 211369251 | 34 | 1905990 | 1 | 1 |
| 2021-10-21 | 3 | PRIMARY DOCUMENT | 0001562180-21-006607 | 13512 | ||||||
| 2021-10-06 | 8-K | 8-K | 5.02,8.01,9.01 | 0001193125-21-292635 | 001-37471 | 211308837 | 34 | 172523 | 1 | 1 |
| 2021-09-01 | 4 | PRIMARY DOCUMENT | 0001562180-21-005712 | 13740 | ||||||
| 2021-08-30 | 8-K | 8-K | 7.01,9.01 | 0001583648-21-000041 | 001-37471 | 211221446 | 34 | 3817127 | 1 | 1 |
| 2021-08-24 | 8-K | 8-K | 7.01,8.01,9.01 | 0001583648-21-000039 | 001-37471 | 211198912 | 34 | 1351066 | 1 | 1 |
| 2021-08-13 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2021-08-13 16:00:00 | 9999999995-21-003203 | 333-258497 | 211174178 | 33 | 1800 | ||
| 2021-08-11 | CORRESP | filename1.htm | 0001193125-21-243157 | 7180 | ||||||
| 2021-08-11 | UPLOAD | filename1.pdf | 0000000000-21-009807 | 40242 | ||||||
| 2021-08-05 | S-8 | S-8 | 0001193125-21-237847 | 333-258502 | 211149164 | 33 | 256795 | |||
| 2021-08-05 | S-3 | S-3 | 0001193125-21-237835 | 333-258497 | 211149101 | 33 | 1276421 | |||
| 2021-08-05 | 10-Q | 10-Q | 0001583648-21-000034 | 001-37471 | 211148058 | 34 | 51494828 | 1 | 1 | |
| 2021-08-04 | 8-K | 8-K | 2.02,7.01,9.01 | 0001583648-21-000030 | 001-37471 | 211142334 | 34 | 10233834 | 1 | 1 |
| 2021-08-03 | 4 | PRIMARY DOCUMENT | 0001562180-21-005129 | 8934 | ||||||
| 2021-08-03 | 3 | PRIMARY DOCUMENT | 0001562180-21-005128 | 6519 | ||||||
| 2021-08-03 | 3 | PRIMARY DOCUMENT | 0001562180-21-005125 | 15097 | ||||||
| 2021-07-12 | SC 13G/A | us7207951036_071021.txt | 0000834237-21-008731 | 005-88917 | 211084421 | 34 | 12241 | |||
| 2021-07-06 | SC 13G | PIERIS PHARMACEUTICALS, INC. | 0001104659-21-089388 | 005-88917 | 211074067 | 34 | 159793 | |||
| 2021-06-29 | 4 | PRIMARY DOCUMENT | 0001562180-21-004564 | 5607 | ||||||
| 2021-06-29 | 4 | PRIMARY DOCUMENT | 0001562180-21-004563 | 9091 | ||||||
| 2021-06-29 | 4 | PRIMARY DOCUMENT | 0001562180-21-004562 | 5571 | ||||||
| 2021-06-29 | 4 | PRIMARY DOCUMENT | 0001562180-21-004561 | 5477 | ||||||
| 2021-06-29 | 4 | PRIMARY DOCUMENT | 0001562180-21-004560 | 5599 | ||||||
| 2021-06-29 | 4 | PRIMARY DOCUMENT | 0001562180-21-004559 | 5605 | ||||||
| 2021-06-29 | 4 | PRIMARY DOCUMENT | 0001562180-21-004558 | 5600 | ||||||
| 2021-06-29 | 8-K | 8-K | 5.02,5.07,9.01 | 0001193125-21-203278 | 001-37471 | 211058254 | 34 | 301477 | 1 | 1 |
| 2021-06-25 | 8-K | 8-K | 7.01,9.01 | 0001628280-21-012877 | 001-37471 | 211044710 | 34 | 9744631 | 1 | 1 |
| 2021-06-01 | 424B3 | 424B3 | 0001193125-21-178493 | 333-256218 | 21985201 | 33 | 138746 | |||
| 2021-05-28 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2021-05-28 16:00:00 | 9999999995-21-002161 | 333-256218 | 21982691 | 33 | 1799 | ||
| 2021-05-26 | CORRESP | filename1.htm | 0001193125-21-173331 | 7173 | ||||||
| 2021-05-25 | 8-K | 8-K | 7.01,9.01 | 0001583648-21-000028 | 001-37471 | 21957391 | 34 | 6815852 | 1 | 1 |
| 2021-05-25 | 8-K | 8-K | 1.01,9.01 | 0001583648-21-000026 | 001-37471 | 21957386 | 34 | 1037701 | 1 | 1 |
| 2021-05-21 | 8-K | 8-K | 1.01,3.02,3.03,5.03,9.01 | 0001193125-21-169379 | 001-37471 | 21949808 | 34 | 404880 | 1 | 1 |
| 2021-05-19 | UPLOAD | filename1.pdf | 0000000000-21-006366 | 40241 | ||||||
| 2021-05-17 | S-3 | S-3 | 0001193125-21-163947 | 333-256218 | 21932560 | 33 | 223963 | |||
| 2021-05-17 | 10-Q | 10-Q | 0001583648-21-000023 | 001-37471 | 21931200 | 34 | 77476954 | 1 | 1 | |
| 2021-05-17 | 8-K | 8-K | 2.02,9.01 | 0001583648-21-000018 | 001-37471 | 21927503 | 34 | 1911493 | 1 | 1 |
| 2021-04-29 | DEFA14A | DEFA14A | 0001583648-21-000016 | 001-37471 | 21870371 | 34 | 1208146 | |||
| 2021-04-29 | DEF 14A | DEF 14A | 0001583648-21-000015 | 001-37471 | 21870332 | 34 | 1348933 | |||
| 2021-04-26 | 8-K | 8-K | 1.01,9.01 | 0001583648-21-000009 | 001-37471 | 21851863 | 34 | 1016285 | 1 | 1 |
| 2021-04-12 | 8-K | 8-K | 7.01,9.01 | 0001583648-21-000007 | 001-37471 | 21819656 | 34 | 10674799 | 1 | 1 |
| 2021-04-08 | SC 13G | SC 13G | 0001104659-21-047684 | 005-88917 | 21813179 | 34 | 107417 | |||
| 2021-04-02 | SC 13G | SC 13G | 0001193125-21-105170 | 005-88917 | 21802210 | 34 | 43799 | |||
| 2021-03-31 | 10-K | 10-K | 0001583648-21-000005 | 001-37471 | 21794642 | 34 | 18604766 | 1 | 1 | |
| 2021-03-30 | 8-K | 8-K | 2.02,7.01,9.01 | 0001628280-21-006064 | 001-37471 | 21783646 | 34 | 9351787 | 1 | 1 |
| 2021-03-30 | 8-K | 8-K | 1.01,3.02 | 0001628280-21-006061 | 001-37471 | 21783611 | 34 | 188987 | 1 | 1 |
| 2021-03-25 | 8-K | 8-K | 1.01,3.02,8.01,9.01 | 0001583648-21-000002 | 001-37471 | 21770250 | 34 | 1379589 | 1 | 1 |
| 2021-03-08 | 4 | PRIMARY DOCUMENT | 0001562180-21-002058 | 9082 | ||||||
| 2021-03-08 | 4 | PRIMARY DOCUMENT | 0001562180-21-002057 | 9109 | ||||||
| 2021-03-08 | 4 | PRIMARY DOCUMENT | 0001562180-21-002056 | 5613 | ||||||
| 2021-02-16 | SC 13G/A | pirs_13g.htm | 0001591986-21-000005 | 005-88917 | 21638527 | 34 | 80407 | |||
| 2021-02-16 | SC 13G | SCHEDULE 13G | 0001213900-21-009249 | 005-88917 | 21632455 | 34 | 164809 | |||
| 2021-02-12 | SC 13G/A | AMENDMENT NO. 7 TO THE SCHEDULE 13G | 0000921895-21-000382 | 005-88917 | 21627802 | 34 | 312145 | |||
| 2021-01-29 | SC 13G/A | us7207951036_012921.txt | 0000834237-21-004873 | 005-88917 | 21572816 | 34 | 13227 | |||
| 2020-12-15 | 8-K | 8-K | 7.01,9.01 | 0001583648-20-000065 | 001-37471 | 201388272 | 34 | 6206993 | 1 | 1 |
| 2020-11-04 | 10-Q | 10-Q | 0001583648-20-000061 | 001-37471 | 201287561 | 34 | 18450088 | 1 | 1 | |
| 2020-11-04 | 8-K | 8-K | 2.02,9.01 | 0001583648-20-000057 | 001-37471 | 201285150 | 34 | 1803126 | 1 | 1 |
| 2020-09-21 | 8-K | 8-K | 7.01,9.01 | 0001583648-20-000055 | 001-37471 | 201185587 | 34 | 4410824 | 1 | 1 |
| 2020-09-21 | 8-K | 8-K | 7.01,9.01 | 0001583648-20-000053 | 001-37471 | 201185198 | 34 | 3251364 | 1 | 1 |
| 2020-09-09 | 8-K | 8-K | 7.01,9.01 | 0001583648-20-000050 | 001-37471 | 201165680 | 34 | 5604496 | 1 | 1 |
| 2020-08-10 | S-8 | S-8 | 0001193125-20-215001 | 333-243735 | 201090065 | 33 | 85829 | |||
| 2020-08-10 | 10-Q | 10-Q | 0001583648-20-000046 | 001-37471 | 201089770 | 34 | 7956175 | 1 | 1 | |
| 2020-08-10 | 8-K | 8-K | 2.02,9.01 | 0001583648-20-000044 | 001-37471 | 201087139 | 34 | 329662 | 1 | 1 |
| 2020-08-10 | 8-K | 8-K | 1.01,9.01 | 0001583648-20-000042 | 001-37471 | 201087135 | 34 | 225731 | 1 | 1 |
| 2020-08-07 | CT ORDER | filename1.pdf | 20200807,20200807 | 9999999997-20-004330 | 001-37471 | 201083947 | 34 | 124053 | ||
| 2020-07-22 | 4 | PRIMARY DOCUMENT | 0001591986-20-000011 | 5811 | ||||||
| 2020-07-20 | 8-K | 8-K | 8.01,9.01 | 0001583648-20-000039 | 001-37471 | 201036584 | 34 | 226814 | 1 | 1 |
| 2020-06-29 | 8-K | 8-K | 5.02,5.07,9.01 | 0001583648-20-000037 | 001-37471 | 20997952 | 34 | 5543527 | 1 | 1 |
| 2020-06-25 | 4/A | PRIMARY DOCUMENT | 0001562180-20-004696 | 5531 | ||||||
| 2020-06-25 | 4/A | PRIMARY DOCUMENT | 0001562180-20-004695 | 9145 | ||||||
| 2020-06-25 | 4 | PRIMARY DOCUMENT | 0001562180-20-004693 | 9068 | ||||||
| 2020-06-25 | 4 | PRIMARY DOCUMENT | 0001562180-20-004692 | 5587 | ||||||
| 2020-06-25 | 4 | PRIMARY DOCUMENT | 0001562180-20-004691 | 5548 | ||||||
| 2020-06-25 | 4 | PRIMARY DOCUMENT | 0001562180-20-004689 | 5454 | ||||||
| 2020-06-25 | 4 | PRIMARY DOCUMENT | 0001562180-20-004688 | 5577 | ||||||
| 2020-06-25 | 4 | PRIMARY DOCUMENT | 0001562180-20-004687 | 5582 | ||||||
| 2020-06-25 | 4 | PRIMARY DOCUMENT | 0001562180-20-004686 | 5578 |
One latest value per concept from companyfacts (430 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 14.62M | 2026-11-02 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 196.70M | 2025-06-30 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 | |
| ecd | NonPeoNeoAvgCompActuallyPaidAmt | NonPeoNeoAvgCompActuallyPaidAmt | USD | 21.47M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-30 | 0001104659-26-052875 | ||
| ecd | NonPeoNeoAvgTotalCompAmt | NonPeoNeoAvgTotalCompAmt | USD | 1.98M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-30 | 0001104659-26-052875 | ||
| ecd | TotalShareholderRtnAmt | TotalShareholderRtnAmt | USD | 125.81 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-30 | 0001104659-26-052875 | ||
| ffd | NetFeeAmt | NetFeeAmt | USD | 14,393.82 | 2026-08-04 | S-8 | 2026-08-04 | 0001104659-26-090394 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 14,393.82 | 2026-08-04 | S-8 | 2026-08-04 | 0001104659-26-090394 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 104.23M | 2026-08-04 | S-8 | 2026-08-04 | 0001104659-26-090394 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-08-04 | S-8 | 2026-08-04 | 0001104659-26-090394 | |||
| us-gaap | AccountsPayableAndOtherAccruedLiabilitiesCurrent | Accounts Payable and Other Accrued Liabilities, Current | USD | 10.79M | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-04 | 0001583648-22-000065 | |
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 5.16M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 | |
| us-gaap | AccountsPayableTradeCurrent | Accounts Payable, Trade, Current | USD | 4.52M | 2016-09-30 | 2016 | Q3 | 10-Q | 2016-11-10 | 0001193125-16-765868 | |
| us-gaap | AccountsReceivableNetCurrent | Accounts Receivable, after Allowance for Credit Loss, Current | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | 524,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 |
| us-gaap | AccruedBonusesCurrent | Accrued Bonuses, Current | USD | 252,953 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-30 | 0001193125-15-109883 | |
| us-gaap | AccruedEnvironmentalLossContingenciesNoncurrent | Accrued Environmental Loss Contingencies, Noncurrent | USD | 5,581 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-13 | 0001193125-15-376834 | |
| us-gaap | AccruedIncomeTaxes | Accrued Income Taxes | USD | 1.06M | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-13 | 0001193125-17-339158 | |
| us-gaap | AccruedLiabilitiesAndOtherLiabilities | Accrued Liabilities and Other Liabilities | USD | 23,852 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-23 | 0001193125-16-514870 | |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 19.68M | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-02 | 0001583648-21-000047 | |
| us-gaap | AccruedLiabilitiesCurrentAndNoncurrent | Accrued Liabilities | USD | 1.76M | 2015-12-31 | 2015 | FY | 10-K | 2016-03-23 | 0001193125-16-514870 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 392,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 | |
| us-gaap | AccruedSalariesCurrent | Accrued Salaries, Current | USD | 704,597 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-23 | 0001193125-16-514870 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 9.65M | 2022-12-31 | 2023 | FY | 10-K | 2024-03-29 | 0001437749-24-010123 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | 56,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 395.58M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 316.25M | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-04 | 0001583648-22-000065 | |
| us-gaap | AdditionalPaidInCapitalPreferredStock | Additional Paid in Capital, Preferred Stock | USD | 22,750 | 2014-09-30 | 2015 | Q1 | 10-Q | 2014-11-13 | 0001583648-14-000012 | |
| us-gaap | AdjustmentOfWarrantsGrantedForServices | Adjustment of Warrants Granted for Services | USD | 664,064 | 2014-01-01 | 2014-12-31 | 2015 | FY | 10-K | 2016-03-23 | 0001193125-16-514870 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 5.42M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | USD | 5,000 | 2026-04-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 13.95M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 |
| us-gaap | AllowanceForDoubtfulAccountsReceivableCurrent | Accounts Receivable, Allowance for Credit Loss, Current | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-02 | 0001583648-22-000016 | |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 500,000 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-13 | 0001437749-24-034891 |
| us-gaap | AssetBackedSecuritiesAtCarryingValue | Asset-Backed Securities, at Carrying Value | USD | 7.95M | 2019-12-31 | 2019 | FY | 10-K | 2020-03-13 | 0001583648-20-000015 | |
| us-gaap | AssetImpairmentCharges | Asset Impairment Charges | USD | 0 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-13 | 0001437749-24-034891 |
| us-gaap | Assets | Assets | USD | 239.40M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 238.97M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 | |
| us-gaap | AssetsHeldForSaleNotPartOfDisposalGroupCurrent | Assets Held-for-sale, Not Part of Disposal Group, Current | USD | 0 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-13 | 0001437749-24-034891 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | USD | 367,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 407,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 43.42M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 | |
| us-gaap | AvailableForSaleSecurities | Available-for-sale Securities | USD | 41.89M | 2019-12-31 | 2019 | FY | 10-K | 2020-03-13 | 0001583648-20-000015 | |
| us-gaap | AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax | USD | 57,000 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-13 | 0001583648-20-000015 | |
| us-gaap | AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax | USD | 127,000 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-13 | 0001583648-20-000015 | |
| us-gaap | AvailableForSaleSecuritiesAmortizedCost | Available-for-sale Securities, Amortized Cost Basis | USD | 53.38M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-18 | 0001583648-19-000011 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 43.38M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 | |
| us-gaap | AvailableForSaleSecuritiesGrossRealizedGainLossNet | Available-for-sale Securities, Gross Realized Gain (Loss) | USD | 0 | 2017-01-01 | 2017-06-30 | 2018 | Q2 | 10-Q | 2018-08-09 | 0001583648-18-000049 |
| us-gaap | BusinessAcquisitionCostOfAcquiredEntityTransactionCosts | Business Acquisition, Transaction Costs | USD | 2.50M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 | |
| us-gaap | BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets | USD | 14.75M | 2024-12-13 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 | |
| us-gaap | BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents | USD | 13.78M | 2024-12-13 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 | |
| us-gaap | BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets | USD | 14.75M | 2024-12-13 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 | |
| us-gaap | BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets | USD | 595,000 | 2024-12-13 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 | |
| us-gaap | BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables | USD | 377,000 | 2024-12-13 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 | |
| us-gaap | BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities | USD | 3.14M | 2024-12-13 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 | |
| us-gaap | BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable | USD | 142,000 | 2024-12-13 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 | |
| us-gaap | BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities | USD | 3.14M | 2024-12-13 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 | |
| us-gaap | BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net | USD | 11.61M | 2024-12-13 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 0 | 2024-01-01 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-14 | 0001437749-24-026778 |
| us-gaap | CapitalizedContractCostAmortization | Capitalized Contract Cost, Amortization | USD | 100,000 | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-02 | 0001583648-22-000016 |
| us-gaap | Cash | Cash | USD | 89.92M | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-13 | 0001193125-17-339158 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 193.30M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 | |
| us-gaap | CashAndCashEquivalentsFairValueDisclosure | Cash and Cash Equivalents, Fair Value Disclosure | USD | 11.89M | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-13 | 0001437749-24-034891 | |
| us-gaap | CashAndCashEquivalentsPeriodIncreaseDecrease | Cash and Cash Equivalents, Period Increase (Decrease) | USD | 36.99M | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-18 | 0001583648-19-000011 |
| us-gaap | CashCashEquivalentsAndShortTermInvestments | Cash, Cash Equivalents, and Short-term Investments | USD | 236.70M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 54.26M | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-04 | 0001583648-22-000065 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | 193.30M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 135.31M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 |
| us-gaap | CashEquivalentsAtCarryingValue | Cash Equivalents, at Carrying Value | USD | 34.90M | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-02 | 0001583648-21-000047 | |
| us-gaap | ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 | Class of Warrant or Right, Exercise Price of Warrants or Rights | USD/shares | 2 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-23 | 0001193125-16-514870 | |
| us-gaap | ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights | Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 123,238 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-13 | 0001583648-20-000015 | |
| us-gaap | CommercialPaperAtCarryingValue | Commercial Paper, at Carrying Value | USD | 10.91M | 2018-12-31 | 2019 | FY | 10-K | 2020-03-13 | 0001583648-20-000015 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 200.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 14.61M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 14.61M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 15,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -62.31M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 |
| us-gaap | ContractWithCustomerAssetGross | Contract with Customer, Asset, before Allowance for Credit Loss | USD | 1.10M | 2017-05-02 | 2019 | FY | 10-K | 2020-03-13 | 0001583648-20-000015 | |
| us-gaap | ContractWithCustomerAssetNet | Contract with Customer, Asset, after Allowance for Credit Loss | USD | 300,000 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-13 | 0001583648-20-000015 | |
| us-gaap | ContractWithCustomerLiabilityCurrent | Contract with Customer, Liability, Current | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-29 | 0001437749-24-010123 | |
| us-gaap | ContractWithCustomerLiabilityNoncurrent | Contract with Customer, Liability, Noncurrent | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-29 | 0001437749-24-010123 | |
| us-gaap | ContractWithCustomerLiabilityRevenueRecognized | Contract with Customer, Liability, Revenue Recognized | USD | 38.70M | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-14 | 0001437749-23-031957 |
| us-gaap | ConvertibleNotesPayable | Convertible Notes Payable | USD | 18.43M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 | |
| us-gaap | ConvertiblePreferredStockSharesIssuedUponConversion | Convertible Preferred Stock, Shares Issued upon Conversion | shares | 13.34 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 | |
| us-gaap | CostsAndExpenses | Costs and Expenses | USD | 7.61M | 2015-01-01 | 2015-06-30 | 2015 | Q2 | 10-Q | 2015-08-13 | 0001193125-15-290039 |
| us-gaap | CostsAndExpensesRelatedParty | Costs and Expenses, Related Party | USD | 0 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-30 | 0001193125-17-102052 |
| us-gaap | CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption | Cumulative Effect of New Accounting Principle in Period of Adoption (Deprecated 2020-01-31) | USD | -1.64M | 2019-01-01 | 2020 | Q1 | 10-Q | 2020-05-11 | 0001583648-20-000026 | |
| us-gaap | CurrentFederalTaxExpenseBenefit | Current Federal Tax Expense (Benefit) | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-29 | 0001437749-24-010123 |
| us-gaap | CurrentForeignTaxExpenseBenefit | Current Foreign Tax Expense (Benefit) | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-29 | 0001437749-24-010123 |
| us-gaap | CurrentIncomeTaxExpenseBenefit | Current Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 |
| us-gaap | CurrentStateAndLocalTaxExpenseBenefit | Current State and Local Tax Expense (Benefit) | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-29 | 0001437749-24-010123 |
| us-gaap | DebtConversionConvertedInstrumentAmount1 | Debt Conversion, Converted Instrument, Amount | USD | 4.38M | 2014-01-01 | 2014-12-31 | 2015 | FY | 10-K | 2016-03-23 | 0001193125-16-514870 |
| us-gaap | DebtInstrumentConvertibleBeneficialConversionFeature | Debt Instrument, Convertible, Beneficial Conversion Feature | USD | 2.24M | 2014-01-01 | 2014-12-31 | 2015 | FY | 10-K | 2016-03-23 | 0001193125-16-514870 |
| us-gaap | DebtInstrumentFairValue | Debt Instrument, Fair Value Disclosure | USD | 0 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-13 | 0001193125-17-339158 | |
| us-gaap | DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss | Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss | USD | 300,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 | |
| us-gaap | DebtSecuritiesAvailableForSaleRealizedGainLoss | Debt Securities, Available-for-sale, Realized Gain (Loss) | USD | 0 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-13 | 0001437749-24-034891 |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions | Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions | Position | 7 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 | |
| us-gaap | DeferredFederalIncomeTaxExpenseBenefit | Deferred Federal Income Tax Expense (Benefit) | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-29 | 0001437749-24-010123 |
| us-gaap | DeferredForeignIncomeTaxExpenseBenefit | Deferred Foreign Income Tax Expense (Benefit) | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-29 | 0001437749-24-010123 |
| us-gaap | DeferredIncomeTaxesAndTaxCredits | Deferred Income Taxes and Tax Credits | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-02 | 0001583648-22-000016 |
| us-gaap | DeferredIncomeTaxExpenseBenefit | Deferred Income Tax Expense (Benefit) | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-29 | 0001437749-24-010123 |
| us-gaap | DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-29 | 0001437749-24-010123 | |
| us-gaap | DeferredOfferingCosts | Deferred Offering Costs | USD | 1.00M | 2019-12-31 | 2019 | FY | 10-K | 2020-03-13 | 0001583648-20-000015 | |
| us-gaap | DeferredRentAssetNetCurrent | Deferred Rent Asset, Net, Current | USD | 12.10M | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001583648-19-000075 | |
| us-gaap | DeferredRentReceivablesNet | Deferred Rent Receivables, Net | USD | 0 | 2019-01-01 | 2019 | FY | 10-K | 2020-03-13 | 0001583648-20-000015 | |
| us-gaap | DeferredRevenueCurrent | Deferred Revenue, Current | USD | 35.61M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-18 | 0001583648-19-000011 | |
| us-gaap | DeferredRevenueNoncurrent | Deferred Revenue, Noncurrent | USD | 53.30M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-18 | 0001583648-19-000011 | |
| us-gaap | DeferredStateAndLocalIncomeTaxExpenseBenefit | Deferred State and Local Income Tax Expense (Benefit) | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-29 | 0001437749-24-010123 |
| us-gaap | DeferredTaxAssetsDeferredIncome | Deferred Tax Assets, Deferred Income | USD | 0 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-13 | 0001583648-20-000015 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 106.68M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 106.14M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 | |
| us-gaap | DeferredTaxAssetsNetNoncurrent | Deferred Tax Assets, Net of Valuation Allowance, Noncurrent | USD | 24,464 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-13 | 0001193125-15-376834 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 91.96M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsForeign | Deferred Tax Assets, Operating Loss Carryforwards, Foreign | USD | 8.90M | 2015-12-31 | 2016 | FY | 10-K | 2017-03-30 | 0001193125-17-102052 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 10,149 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-23 | 0001193125-16-514870 | |
| us-gaap | DeferredTaxAssetsPropertyPlantAndEquipment | Deferred Tax Assets, Property, Plant and Equipment | USD | 12,065 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-30 | 0001193125-17-102052 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwards | Deferred Tax Assets, Tax Credit Carryforwards | USD | 199,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsOther | Deferred Tax Assets, Tax Credit Carryforwards, Other | USD | 589,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsResearch | Deferred Tax Assets, Tax Credit Carryforwards, Research | USD | 644,000 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-29 | 0001437749-24-010123 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits | USD | 2.62M | 2023-12-31 | 2023 | FY | 10-K | 2024-03-29 | 0001437749-24-010123 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 1.79M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseOther | Deferred Tax Assets, Tax Deferred Expense, Other | USD | 102,935 | 2013-12-31 | 2014 | FY | 10-K | 2015-03-30 | 0001193125-15-109883 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Provision for Loan Losses | USD | 12,653 | 2014-12-31 | 2015 | FY | 10-K | 2016-03-23 | 0001193125-16-514870 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves | USD | 35,888 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-30 | 0001193125-17-102052 | |
| us-gaap | DeferredTaxAssetsUnrealizedCurrencyLosses | Deferred Tax Assets, Unrealized Currency Losses | USD | 377,000 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-29 | 0001437749-24-010123 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 106.14M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 | |
| us-gaap | DeferredTaxAssetsValuationAllowanceNoncurrent | Deferred Tax Assets, Valuation Allowance, Noncurrent | USD | -5,435 | 2014-06-30 | 2015 | Q1 | 10-Q | 2014-12-12 | 0001477932-14-007008 | |
| us-gaap | DeferredTaxLiabilitiesCurrent | Deferred Tax Liabilities, Net, Current | USD | 24,464 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-13 | 0001193125-15-376834 | |
| us-gaap | DeferredTaxLiabilitiesDeferredExpense | Deferred Tax Liabilities, Deferred Expense | USD | 0 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-31 | 0001437749-23-008834 | |
| us-gaap | DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals | Deferred Tax Liabilities, Deferred Expense, Reserves and Accruals | USD | 8,811 | 2014-12-31 | 2015 | FY | 10-K | 2016-03-23 | 0001193125-16-514870 | |
| us-gaap | DeferredTaxLiabilitiesOther | Deferred Tax Liabilities, Other | USD | 400,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 | |
| us-gaap | DeferredTaxLiabilitiesPrepaidExpenses | Deferred Tax Liabilities, Prepaid Expenses | USD | 9,438 | 2014-12-31 | 2015 | FY | 10-K | 2016-03-23 | 0001193125-16-514870 | |
| us-gaap | DeferredTaxLiabilitiesPropertyPlantAndEquipment | Deferred Tax Liabilities, Property, Plant and Equipment | USD | 30,646 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-30 | 0001193125-15-109883 | |
| us-gaap | DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities | Deferred Tax Liabilities, Unrealized Gains on Trading Securities | USD | 0 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-13 | 0001583648-20-000015 | |
| us-gaap | DefinedContributionPlanCostRecognized | Defined Contribution Plan, Cost | USD | 45,000 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-15 | 0001583648-18-000017 |
| us-gaap | Depreciation | Depreciation | USD | 1.80M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-29 | 0001437749-24-010123 |
| us-gaap | DepreciationAmortizationAndAccretionNet | Depreciation, Amortization and Accretion, Net | USD | -30,000 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-13 | 0001437749-24-034891 |
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 1.90M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-29 | 0001437749-24-010123 |
| us-gaap | DerivativeLiabilitiesCurrent | Derivative Liability, Current | USD | 2.60M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 | |
| us-gaap | DerivativeLiabilitiesNoncurrent | Derivative Liability, Noncurrent | USD | 1.37M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 | |
| us-gaap | DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage | Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) | USD | 15,986 | 2014-06-30 | 2015 | Q1 | 10-Q | 2014-12-12 | 0001477932-14-007008 | |
| us-gaap | DueToOfficersOrStockholdersNoncurrent | Due to Officers or Stockholders, Noncurrent | USD | 3.10M | 2013-12-31 | 2014 | FY | 10-K | 2015-03-30 | 0001193125-15-109883 | |
| us-gaap | DueToRelatedPartiesNoncurrent | Due to Related Parties, Noncurrent | USD | 474 | 2014-09-30 | 2015 | Q1 | 10-Q | 2014-11-13 | 0001583648-14-000012 | |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -4.45 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -0.07 | 2021-01-01 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-17 | 0001583648-21-000023 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -4.45 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.206 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent | pure | 0 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-13 | 0001583648-20-000015 |
| us-gaap | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpense | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent | pure | -0.008 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | -0.021 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-29 | 0001437749-24-010123 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | -0.01 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 |
| us-gaap | EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings | Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Percent | pure | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-02 | 0001583648-22-000016 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0.042 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0000950170-25-047212 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Percent | pure | -0.014 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 |
| us-gaap | EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations | Effect of Exchange Rate on Cash and Cash Equivalents, Continuing Operations | USD | -1.58M | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-18 | 0001583648-19-000011 |
| us-gaap | EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | -111,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 |
| us-gaap | EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | 3,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0000950170-25-047212 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 3.04M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized | Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | USD | 4.30M | 2023-12-31 | 2023 | FY | 10-K | 2024-03-29 | 0001437749-24-010123 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | USD | 61.50M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 | |
| us-gaap | FairValueAdjustmentOfWarrants | Fair Value Adjustment of Warrants | USD | 0 | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-23 | 0001193125-16-514870 |
| us-gaap | FairValueOptionChangesInFairValueGainLoss1 | Fair Value, Option, Changes in Fair Value, Gain (Loss) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 |
| us-gaap | ForeignCurrencyTransactionGainLossUnrealized | Foreign Currency Transaction Gain (Loss), Unrealized | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-02 | 0001583648-22-000016 |
| us-gaap | GainLossOnContractTermination | Gain (Loss) on Contract Termination | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0000950170-25-047212 |
| us-gaap | GainLossOnDispositionOfAssets1 | Gain (Loss) on Disposition of Assets | USD | 200,000 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-13 | 0001437749-24-034891 |
| us-gaap | GainsLossesOnExtinguishmentOfDebt | Gain (Loss) on Extinguishment of Debt | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0000950170-25-047212 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 26.36M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 |
| us-gaap | GovernmentAssistanceAmount | GovernmentAssistanceAmount | USD | 500,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 |
| us-gaap | GovernmentAssistanceOperatingIncome | GovernmentAssistanceOperatingIncome | USD | 600,000 | 2025-10-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 | |
| us-gaap | GrantsReceivable | Grants Receivable | USD | 600,000 | 2025-10-31 | 2025 | Q3 | 10-Q | 2025-11-12 | 0001193125-25-276119 | |
| us-gaap | GrantsReceivableCurrent | Grants Receivable, Current | USD | 0 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-13 | 0001437749-24-034891 | |
| us-gaap | ImpairmentOfLongLivedAssetsHeldForUse | Impairment of Long-Lived Assets Held-for-use | USD | 0 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-18 | 0001583648-19-000011 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic | Income (Loss) from Continuing Operations before Income Taxes, Domestic | USD | -41.78M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -62.28M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign | Income (Loss) from Continuing Operations before Income Taxes, Foreign | USD | 64,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments | Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest | USD | -37.07M | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-31 | 0001583648-21-000005 |
| us-gaap | IncomeTaxesPaid | Income Taxes Paid | USD | 0 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-13 | 0001583648-20-000015 |
| us-gaap | IncomeTaxesPaidNet | Income Taxes Paid, Net | USD | 1,206 | 2015-01-01 | 2015-06-30 | 2015 | Q2 | 10-Q | 2015-08-13 | 0001193125-15-290039 |
| us-gaap | IncomeTaxesReceivable | Income Taxes Receivable, Current | USD | 3,534 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-13 | 0001193125-15-376834 | |
| us-gaap | IncomeTaxExaminationPenaltiesAndInterestExpense | Income Tax Examination, Penalties and Interest Expense | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 8.58M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 |
| us-gaap | IncomeTaxReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount | USD | 420,337 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-30 | 0001193125-15-109883 |
| us-gaap | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount | USD | 4,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -8.76M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpense | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount | USD | 330,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 |
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | 408,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 |
| us-gaap | IncomeTaxReconciliationPriorYearIncomeTaxes | Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount | USD | 7.31M | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-30 | 0001193125-15-109883 |
| us-gaap | IncomeTaxReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Amount | USD | 564,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | 650 | 2013-05-24 | 2014-06-30 | 2014 | FY | 10-K | 2014-09-12 | 0001583648-14-000010 |
| us-gaap | IncreaseDecreaseInAccountsPayableTrade | Increase (Decrease) in Accounts Payable, Trade | USD | 496,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 |
| us-gaap | IncreaseDecreaseInAccountsReceivable | Increase (Decrease) in Accounts Receivable | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 |
| us-gaap | IncreaseDecreaseInAccruedLiabilities | Increase (Decrease) in Accrued Liabilities | USD | 1,250 | 2013-07-01 | 2013-09-30 | 2015 | Q1 | 10-Q | 2014-12-12 | 0001477932-14-007008 |
| us-gaap | IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities | USD | 2.63M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 |
| us-gaap | IncreaseDecreaseInContractWithCustomerLiability | Increase (Decrease) in Contract with Customer, Liability | USD | 0 | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-14 | 0001437749-23-031957 |
| us-gaap | IncreaseDecreaseInDeferredRevenue | Increase (Decrease) in Deferred Revenue | USD | -39.97M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-29 | 0001437749-24-010123 |
| us-gaap | IncreaseDecreaseInDerivativeLiabilities | Increase (Decrease) in Derivative Liabilities | USD | 1.88M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 |
| us-gaap | IncreaseDecreaseInIncomeTaxes | Increase (Decrease) in Income Taxes | USD | 10,109 | 2015-01-01 | 2015-09-30 | 2016 | Q3 | 10-Q | 2016-11-10 | 0001193125-16-765868 |
| us-gaap | IncreaseDecreaseInOperatingCapital | Increase (Decrease) in Operating Capital | USD | -89,000 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-13 | 0001437749-24-034891 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | -148,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 |
| us-gaap | IncreaseDecreaseInOtherCurrentAssets | Increase (Decrease) in Other Current Assets | USD | 768,905 | 2015-01-01 | 2015-06-30 | 2015 | Q2 | 10-Q | 2015-08-13 | 0001193125-15-290039 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | 1.23M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 |
| us-gaap | IncreaseDecreaseInPrepaidExpense | Increase (Decrease) in Prepaid Expense | USD | 628,723 | 2015-01-01 | 2015-06-30 | 2015 | Q2 | 10-Q | 2015-08-13 | 0001193125-15-290039 |
| us-gaap | IncreaseDecreaseInPrepaidRent | Increase (Decrease) in Prepaid Rent | USD | 0 | 2019-01-01 | 2019-09-30 | 2020 | Q3 | 10-Q | 2020-11-04 | 0001583648-20-000061 |
| us-gaap | IncreaseDecreaseInRestrictedCash | Increase (Decrease) in Restricted Cash | USD | -70,026 | 2014-01-01 | 2014-12-31 | 2015 | FY | 10-K | 2016-03-23 | 0001193125-16-514870 |
| us-gaap | IncrementalCommonSharesAttributableToShareBasedPaymentArrangements | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements | shares | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0000950170-25-047212 |
| us-gaap | InterestExpense | Interest Expense | USD | 4,223 | 2015-01-01 | 2015-06-30 | 2015 | Q2 | 10-Q | 2015-08-13 | 0001193125-15-290039 |
| us-gaap | InterestExpenseDebt | Interest Expense, Debt | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 |
| us-gaap | InterestIncomeExpenseNet | Interest Income (Expense), Net | USD | 5.59M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 |
| us-gaap | InterestIncomeExpenseNonoperatingNet | Interest Income (Expense), Nonoperating, Net | USD | 610,000 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-13 | 0001437749-24-034891 |
| us-gaap | InterestPaid | Interest Paid, Including Capitalized Interest, Operating and Investing Activities | USD | 206,269 | 2015-01-01 | 2015-12-31 | 2016 | FY | 10-K | 2017-03-30 | 0001193125-17-102052 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 0 | 2013-07-01 | 2013-09-30 | 2015 | Q1 | 10-Q | 2014-12-12 | 0001477932-14-007008 |
| us-gaap | LeaseAndRentalExpense | Operating Leases, Rent Expense | USD | 11.50M | 2019-01-01 | 2019-03-31 | 2019 | FY | 10-K | 2020-03-13 | 0001583648-20-000015 |
| us-gaap | LeaseCost | Lease, Cost | USD | 0 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-13 | 0001437749-24-034891 |
| us-gaap | LegalFees | Legal Fees | USD | 29,087 | 2013-05-24 | 2014-09-30 | 2015 | Q1 | 10-Q | 2014-11-13 | 0001583648-14-000012 |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 736,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive | Lessee, Operating Lease, Liability, to be Paid, after Year Five | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 262,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 205,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 269,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 522,000 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-14 | 0001437749-23-031957 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 103,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 | |
| us-gaap | LessorOperatingLeaseLeaseNotYetCommencedAssumptionAndJudgmentValueOfUnderlyingAssetAmount | Lessor, Operating Lease, Lease Not yet Commenced, Assumption and Judgment, Value of Underlying Asset, Amount | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 | |
| us-gaap | Liabilities | Liabilities | USD | 41.48M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 239.40M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 14.93M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 | |
| us-gaap | LiabilityForUncertainTaxPositionsCurrent | Liability for Uncertainty in Income Taxes, Current | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 | |
| us-gaap | LicenseAndServicesRevenue | License and Services Revenue (Deprecated 2018-01-31) | USD | 26.68M | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-18 | 0001583648-19-000011 |
| us-gaap | LitigationReserveNoncurrent | Estimated Litigation Liability, Noncurrent | USD | 327,937 | 2014-12-31 | 2015 | FY | 10-K | 2016-03-23 | 0001193125-16-514870 | |
| us-gaap | LoansPayableCurrent | Loans Payable, Current | USD | 3,474 | 2014-09-30 | 2015 | Q1 | 10-Q | 2014-12-12 | 0001477932-14-007008 | |
| us-gaap | LoansPayableToBankCurrent | Loans Payable to Bank, Current | USD | 0 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-23 | 0001193125-16-514870 | |
| us-gaap | LongTermInvestments | Long-term Investments | USD | 0 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-18 | 0001583648-19-000011 | |
| us-gaap | LongTermLoansFromBank | Loans Payable to Bank, Noncurrent | USD | 1.45M | 2013-12-31 | 2014 | FY | 10-K | 2015-03-30 | 0001193125-15-109883 | |
| us-gaap | LossContingencyAccrualAtCarryingValue | Loss Contingency Accrual | USD | 327,937 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-30 | 0001193125-15-109883 | |
| us-gaap | LossContingencyDamagesAwardedValue | Loss Contingency, Damages Awarded, Value | EUR | 3.50M | 2015-01-01 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-13 | 0001193125-15-376834 |
| us-gaap | LossContingencyDamagesSoughtValue | Loss Contingency, Damages Sought, Value | EUR | 2.50M | 2014-12-23 | 2015 | FY | 10-K | 2016-03-23 | 0001193125-16-514870 | |
| us-gaap | MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments | Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-02 | 0001583648-22-000016 |
| us-gaap | MoneyMarketFundsAtCarryingValue | Money Market Funds, at Carrying Value | USD | 47.38M | 2019-12-31 | 2019 | FY | 10-K | 2020-03-13 | 0001583648-20-000015 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 216.46M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 |
| us-gaap | NetCashProvidedByUsedInFinancingActivitiesContinuingOperations | Net Cash Provided by (Used in) Financing Activities, Continuing Operations | USD | 48.50M | 2018-01-01 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-07 | 0001583648-18-000074 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -42.90M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 |
| us-gaap | NetCashProvidedByUsedInInvestingActivitiesContinuingOperations | Net Cash Provided by (Used in) Investing Activities, Continuing Operations | USD | -3.66M | 2018-01-01 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-07 | 0001583648-18-000074 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -38.14M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 |
| us-gaap | NetCashProvidedByUsedInOperatingActivitiesContinuingOperations | Net Cash Provided by (Used in) Operating Activities, Continuing Operations | USD | 7.99M | 2018-01-01 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-07 | 0001583648-18-000074 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -62.28M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -29.00M | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-12 | 0001193125-25-276119 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersDiluted | Net Income (Loss) Available to Common Stockholders, Diluted | USD | -17.43M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0000950170-25-047212 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | -2.65M | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-30 | 0001193125-15-109883 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 |
| us-gaap | NumberOfPropertiesSubjectToGroundLeases | Number of Properties Subject to Ground Leases | Sublease | 6 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-23 | 0001193125-16-514870 | |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | Segment | 1 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-04 | 0001193125-26-331574 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 58.99M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -58.99M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 61,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 633,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 225,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 260,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 0 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-13 | 0001437749-24-034891 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 435,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 | |
| us-gaap | OperatingLeaseRightOfUseAssetAmortizationExpense | Operating Lease, Right-of-Use Asset, Amortization Expense | USD | -91,000 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-02 | 0001583648-22-000016 |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDue | Operating Leases, Future Minimum Payments Due | USD | 36.02M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-18 | 0001583648-19-000011 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueCurrent | Operating Leases, Future Minimum Payments Due, Next Twelve Months | USD | 613,000 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-18 | 0001583648-19-000011 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFiveYears | Operating Leases, Future Minimum Payments, Due in Five Years | USD | 2.37M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-18 | 0001583648-19-000011 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFourYears | Operating Leases, Future Minimum Payments, Due in Four Years | USD | 2.35M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-18 | 0001583648-19-000011 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInThreeYears | Operating Leases, Future Minimum Payments, Due in Three Years | USD | 2.46M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-18 | 0001583648-19-000011 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInTwoYears | Operating Leases, Future Minimum Payments, Due in Two Years | USD | 2.46M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-18 | 0001583648-19-000011 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueThereafter | Operating Leases, Future Minimum Payments, Due Thereafter | USD | 25.77M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-18 | 0001583648-19-000011 | |
| us-gaap | OperatingLeasesRentExpenseNet | Operating Leases, Rent Expense, Net | USD | 300,000 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-30 | 0001193125-17-102052 |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.116 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 | |
| us-gaap | OperatingLossCarryforwards | Operating Loss Carryforwards | USD | 15,986 | 2014-06-30 | 2015 | Q1 | 10-Q | 2014-12-12 | 0001477932-14-007008 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 1.03M | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-13 | 0001437749-24-034891 | |
| us-gaap | OtherAccruedLiabilitiesNoncurrent | Other Accrued Liabilities, Noncurrent | USD | 23,852 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-23 | 0001193125-16-514870 | |
| us-gaap | OtherAssetsCurrent | Other Assets, Current | USD | 1.29M | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-13 | 0001193125-15-376834 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-29 | 0001437749-24-010123 | |
| us-gaap | OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent | Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent | USD | 152,000 | 2022-01-01 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-04 | 0001583648-22-000065 |
| us-gaap | OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent | Other Comprehensive Income (Loss), Available-for-sale Securities, Tax, Portion Attributable to Parent | USD | 100,000 | 2019-01-01 | 2019-03-31 | 2020 | Q1 | 10-Q | 2020-05-11 | 0001583648-20-000026 |
| us-gaap | OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax | USD | 13,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 |
| us-gaap | OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax | USD | -1,000 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-13 | 0001437749-24-034891 |
| us-gaap | OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax | USD | -19,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 |
| us-gaap | OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent | USD | -985,885 | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-13 | 0001193125-17-339158 |
| us-gaap | OtherComprehensiveIncomeLossTax | Other Comprehensive Income (Loss), Tax | USD | 0 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-13 | 0001583648-20-000015 |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | USD | -1,000 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-13 | 0001437749-24-034891 |
| us-gaap | OtherCostAndExpenseOperating | Other Cost and Expense, Operating | USD | 817 | 2013-05-26 | 2014-09-30 | 2015 | Q1 | 10-Q | 2014-12-12 | 0001477932-14-007008 |
| us-gaap | OtherDepreciationAndAmortization | Other Depreciation and Amortization | USD | 1.43M | 2022-01-01 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-04 | 0001583648-22-000065 |
| us-gaap | OtherGeneralExpense | Other General Expense | USD | 48 | 2013-05-24 | 2013-12-31 | 2014 | Q2 | 10-Q | 2014-05-14 | 0001583648-14-000005 |
| us-gaap | OtherIncome | Other Income | USD | 0 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-13 | 0001583648-20-000015 |
| us-gaap | OtherLiabilitiesCurrent | Other Liabilities, Current | USD | 1.34M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 | |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 0 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-10 | 0001437749-23-023085 | |
| us-gaap | OtherNoncashIncomeExpense | Other Noncash Income (Expense) | USD | -864,000 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-13 | 0001437749-24-034891 |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | -46,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 |
| us-gaap | OtherReceivablesNetCurrent | Other Receivables, Net, Current | USD | 506,000 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-13 | 0001437749-24-034891 | |
| us-gaap | OtherSalesRevenueNet | Other Revenue, Net (Deprecated 2018-01-31) | USD | 91,000 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-18 | 0001583648-19-000011 |
| us-gaap | PaidInKindInterest | Paid-in-Kind Interest | USD | 2.59M | 2014-01-01 | 2014-12-31 | 2015 | FY | 10-K | 2016-03-23 | 0001193125-16-514870 |
| us-gaap | PartnersCapitalAccountUnitsSoldInPrivatePlacement | Partners' Capital Account, Units, Sold in Private Placement | shares | 8.19M | 2016-06-01 | 2016-06-30 | 2017 | Q3 | 10-Q | 2017-11-13 | 0001193125-17-339158 |
| us-gaap | PaymentForContingentConsiderationLiabilityFinancingActivities | Payment for Contingent Consideration Liability, Financing Activities | USD | 1.98M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 |
| us-gaap | PaymentsOfFinancingCosts | Payments of Financing Costs | USD | 14.25M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 |
| us-gaap | PaymentsOfMergerRelatedCostsFinancingActivities | Payments of Merger Related Costs, Financing Activities | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 154,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 |
| us-gaap | PaymentsToAcquireInvestments | Payments to Acquire Investments | USD | 0 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-13 | 0001437749-24-034891 |
| us-gaap | PaymentsToAcquireMarketableSecurities | Payments to Acquire Marketable Securities | USD | 74.90M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 0 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-13 | 0001437749-24-034891 |
| us-gaap | PreferredStockDividendsIncomeStatementImpact | Preferred Stock Dividends, Income Statement Impact | USD | 0 | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-12 | 0001193125-25-276119 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 10.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 2.29M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 | |
| us-gaap | PrepaidExpenseCurrent | Prepaid Expense, Current | USD | 589,928 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-13 | 0001193125-15-376834 | |
| us-gaap | ProceedsFromContributionsFromAffiliates | Proceeds from Contributions from Affiliates | USD | 474 | 2013-05-24 | 2014-09-30 | 2015 | Q1 | 10-Q | 2014-11-13 | 0001583648-14-000012 |
| us-gaap | ProceedsFromConvertibleDebt | Proceeds from Convertible Debt | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 25.80M | 2015-07-01 | 2015-07-31 | 2016 | FY | 10-K | 2017-03-30 | 0001193125-17-102052 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 230.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 |
| us-gaap | ProceedsFromIssuanceOfPreferredStockAndPreferenceStock | Proceeds from Issuance of Preferred Stock and Preference Stock | USD | 7.34M | 2014-01-01 | 2014-12-31 | 2015 | FY | 10-K | 2016-03-23 | 0001193125-16-514870 |
| us-gaap | ProceedsFromIssuanceOfPrivatePlacement | Proceeds from Issuance of Private Placement | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 |
| us-gaap | ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale | USD | 32.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 |
| us-gaap | ProceedsFromRepaymentOfLoansByEmployeeStockOwnershipPlans | Proceeds from Repayment of Loans by Employee Stock Ownership Plans | USD | 145,000 | 2020-01-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-04 | 0001583648-20-000061 |
| us-gaap | ProceedsFromRepaymentsOfDebt | Proceeds from (Repayments of) Debt | USD | 1.36M | 2014-01-01 | 2014-06-30 | 2015 | Q2 | 10-Q | 2015-08-13 | 0001193125-15-290039 |
| us-gaap | ProceedsFromSaleMaturityAndCollectionsOfInvestments | Proceeds from Sale, Maturity and Collection of Investments | USD | 64.49M | 2018-01-01 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-07 | 0001583648-18-000074 |
| us-gaap | ProceedsFromSaleOfAvailableForSaleSecuritiesDebt | Proceeds from Sale of Debt Securities, Available-for-sale | USD | 0 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-31 | 0001583648-21-000005 |
| us-gaap | ProceedsFromSaleOfProductiveAssets | Proceeds from Sale of Productive Assets | USD | 2.32M | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-13 | 0001437749-24-034891 |
| us-gaap | ProceedsFromSaleOfPropertyPlantAndEquipment | Proceeds from Sale of Property, Plant, and Equipment | USD | 10,888 | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-13 | 0001193125-17-339158 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 2.69M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 |
| us-gaap | ProceedsFromStockPlans | Proceeds from Stock Plans | USD | 0 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-13 | 0001437749-24-034891 |
| us-gaap | ProceedsFromWarrantExercises | Proceeds from Warrant Exercises | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-31 | 0001437749-23-008834 |
| us-gaap | ProfessionalFees | Professional Fees | USD | 29,087 | 2013-05-26 | 2014-09-30 | 2015 | Q1 | 10-Q | 2014-12-12 | 0001477932-14-007008 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -62.28M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 26.64M | 2022-12-31 | 2023 | FY | 10-K | 2024-03-29 | 0001437749-24-010123 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-29 | 0001437749-24-010123 | |
| us-gaap | RealizedInvestmentGainsLosses | Realized Investment Gains (Losses) | USD | 0 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-13 | 0001437749-24-034891 |
| us-gaap | ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock | Receivable from Shareholders or Affiliates for Issuance of Capital Stock | USD | 1.81M | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-02 | 0001583648-21-000047 | |
| us-gaap | RepaymentOfNotesReceivableFromRelatedParties | Repayment of Notes Receivable from Related Parties | USD | 0 | 2013-05-24 | 2014-03-31 | 2014 | Q3 | 10-Q | 2014-06-02 | 0001583648-14-000007 |
| us-gaap | RepaymentsOfDebt | Repayments of Debt | USD | 1.16M | 2015-01-01 | 2015-12-31 | 2016 | FY | 10-K | 2017-03-30 | 0001193125-17-102052 |
| us-gaap | ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned | Research and Development Arrangement, Contract to Perform for Others, Compensation Earned | USD | 1.76M | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-18 | 0001583648-19-000011 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 32.63M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 |
| us-gaap | RestrictedCashAndCashEquivalentsAtCarryingValue | Restricted Cash and Cash Equivalents, Current | USD | 0 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-30 | 0001193125-17-102052 | |
| us-gaap | RestrictedStockExpense | Restricted Stock or Unit Expense | USD | 446,400 | 2015-01-01 | 2015-12-31 | 2016 | FY | 10-K | 2017-03-30 | 0001193125-17-102052 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -197.73M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 | |
| us-gaap | RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer | Revenue from Collaborative Arrangement, Excluding Revenue from Contract with Customer | USD | 47,000 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-13 | 0001437749-24-034891 |
| us-gaap | RevenueFromContractWithCustomerExcludingAssessedTax | Revenue from Contract with Customer, Excluding Assessed Tax | USD | 43.65M | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-13 | 0001583648-20-000015 |
| us-gaap | RevenueFromContractWithCustomerIncludingAssessedTax | Revenue from Contract with Customer, Including Assessed Tax | USD | 6,000 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-13 | 0001437749-24-034891 |
| us-gaap | RevenueFromGrants | Revenue from Grants (Deprecated 2018-01-31) | USD | 369,200 | 2015-01-01 | 2015-12-31 | 2016 | FY | 10-K | 2017-03-30 | 0001193125-17-102052 |
| us-gaap | RevenueNotFromContractWithCustomer | Revenue Not from Contract with Customer | USD | -192,000 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-11 | 0001583648-22-000025 |
| us-gaap | RevenueRecognitionMilestoneMethodRevenueRecognized | Revenue Recognition, Milestone Method, Revenue Recognized | USD | 571,000 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-18 | 0001583648-19-000011 |
| us-gaap | Revenues | Revenues | USD | 53,000 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-13 | 0001437749-24-034891 |
| us-gaap | SaleOfStockPricePerShare | Sale of Stock, Price Per Share | USD/shares | 8 | 2018-02-28 | 2018 | Q3 | 10-Q | 2018-11-07 | 0001583648-18-000074 | |
| us-gaap | SalesRevenueGoodsNet | Sales Revenue, Goods, Net (Deprecated 2018-01-31) | USD | 0 | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-13 | 0001193125-17-339158 |
| us-gaap | SecurityDeposit | Security Deposit | USD | 800,000 | 2018-12-31 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001583648-19-000075 | |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 13.95M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | USD/shares | 138.88 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 0.751 | 2015-01-01 | 2015-03-31 | 2016 | Q1 | 10-Q | 2016-05-12 | 0001193125-16-588539 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum | pure | 1.209 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-31 | 0001583648-21-000005 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum | pure | 0.744 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-31 | 0001583648-21-000005 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.017 | 2015-01-01 | 2015-03-31 | 2016 | Q1 | 10-Q | 2016-05-12 | 0001193125-16-588539 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum | pure | 0.002 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-31 | 0001583648-21-000005 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum | pure | 0.001 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-31 | 0001583648-21-000005 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number | shares | 25,918 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized | Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | shares | 9.97M | 2018-07-24 | 2018 | Q3 | 10-Q | 2018-11-07 | 0001583648-18-000074 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant | Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | shares | 9.28M | 2023-12-31 | 2023 | FY | 10-K | 2024-03-29 | 0001437749-24-010123 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 174.20M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 1.21M | 2015-12-31 | 2015 | FY | 10-K | 2016-03-23 | 0001193125-16-514870 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 2.06 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-23 | 0001193125-16-514870 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 1,000 | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-23 | 0001193125-16-514870 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period | shares | 0 | 2015-04-01 | 2015-06-30 | 2015 | Q2 | 10-Q | 2015-08-13 | 0001193125-15-290039 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price | USD/shares | 0 | 2015-04-01 | 2015-06-30 | 2015 | Q2 | 10-Q | 2015-08-13 | 0001193125-15-290039 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | shares | 112,500 | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-23 | 0001193125-16-514870 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 3.73M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-29 | 0001437749-24-010123 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 67.03 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 391.80M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 2.71M | 2015-12-31 | 2015 | FY | 10-K | 2016-03-23 | 0001193125-16-514870 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 2.05 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-23 | 0001193125-16-514870 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | USD | 741,000 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-23 | 0001193125-16-514870 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares | 2.71M | 2015-12-31 | 2015 | FY | 10-K | 2016-03-23 | 0001193125-16-514870 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | USD/shares | 2.05 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-23 | 0001193125-16-514870 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value | USD | 543,926 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-30 | 0001193125-15-109883 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares | shares | 375,319 | 2015-01-01 | 2015-06-30 | 2015 | Q2 | 10-Q | 2015-08-13 | 0001193125-15-290039 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value | USD/shares | 0.85 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-29 | 0001437749-24-010123 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 2 | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-23 | 0001193125-16-514870 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | USD/shares | 2 | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-23 | 0001193125-16-514870 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 2.47 | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-23 | 0001193125-16-514870 |
| us-gaap | SharesPaidForTaxWithholdingForShareBasedCompensation | Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation | shares | 938 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 |
| us-gaap | ShortTermInvestments | Short-term Investments | USD | 43.38M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 | |
| us-gaap | ShortTermLeaseCost | Short-term Lease, Cost | USD | 53,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 197.92M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 | |
| us-gaap | StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | USD | -904 | 2014-09-30 | 2015 | Q1 | 10-Q | 2014-11-13 | 0001583648-14-000012 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 2.273 | 2014-12-05 | 2015 | FY | 10-K | 2016-03-23 | 0001193125-16-514870 | |
| us-gaap | StockIssuedDuringPeriodSharesConversionOfUnits | Stock Issued During Period, Shares, Conversion of Units | shares | 1 | 2016-06-01 | 2016-06-30 | 2020 | FY | 10-K | 2021-03-31 | 0001583648-21-000005 |
| us-gaap | StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans | Stock Issued During Period, Shares, Employee Stock Purchase Plans | shares | 154,656 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-29 | 0001437749-24-010123 |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 279,075 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-13 | 0001583648-20-000015 |
| us-gaap | StockIssuedDuringPeriodValueAcquisitions | Stock Issued During Period, Value, Acquisitions | USD | 11.61M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 70.60M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfUnits | Stock Issued During Period, Value, Conversion of Units | USD | 0 | 2021-01-01 | 2021-06-30 | 2022 | Q2 | 10-Q | 2022-08-04 | 0001583648-22-000065 |
| us-gaap | StockIssuedDuringPeriodValueEmployeeStockPurchasePlan | Stock Issued During Period, Value, Employee Stock Purchase Plan | USD | 52,000 | 2023-01-01 | 2023-09-30 | 2024 | Q3 | 10-Q | 2024-11-13 | 0001437749-24-034891 |
| us-gaap | StockIssuedDuringPeriodValueIssuedForServices | Stock Issued During Period, Value, Issued for Services | USD | 225,000 | 2015-01-01 | 2015-12-31 | 2016 | FY | 10-K | 2017-03-30 | 0001193125-17-102052 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 215.75M | 2026-01-01 | 2026-03-31 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 |
| us-gaap | StockIssuedDuringPeriodValueRestrictedStockAwardGross | Stock Issued During Period, Value, Restricted Stock Award, Gross | USD | 446,400 | 2015-01-01 | 2015-12-31 | 2016 | FY | 10-K | 2017-03-30 | 0001193125-17-102052 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 452,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 |
| us-gaap | StockRedeemedOrCalledDuringPeriodShares | Stock Redeemed or Called During Period, Shares | shares | 11.36M | 2014-12-17 | 2015 | FY | 10-K | 2016-03-23 | 0001193125-16-514870 | |
| us-gaap | StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased | Stock Repurchase Program, Number of Shares Authorized to be Repurchased | shares | 542,360 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-23 | 0001193125-16-514870 | |
| us-gaap | TemporaryEquityCarryingAmountAttributableToParent | Temporary Equity, Carrying Amount, Attributable to Parent | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0000950170-25-047212 | |
| us-gaap | TemporaryEquityLiquidationPreference | Temporary Equity, Liquidation Preference | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0000950170-25-047212 | |
| us-gaap | TemporaryEquityParOrStatedValuePerShare | Temporary Equity, Par or Stated Value Per Share | USD/shares | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0000950170-25-047212 | |
| us-gaap | TemporaryEquitySharesAuthorized | Temporary Equity, Shares Authorized | shares | 20.66M | 2022-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 | |
| us-gaap | TemporaryEquitySharesIssued | Temporary Equity, Shares Issued | shares | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0000950170-25-047212 | |
| us-gaap | TemporaryEquitySharesOutstanding | Temporary Equity, Shares Outstanding | shares | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0000950170-25-047212 | |
| us-gaap | TradingSecurities | Debt Securities, Trading, and Equity Securities, FV-NI | USD | 28.64M | 2019-12-31 | 2019 | FY | 10-K | 2020-03-13 | 0001583648-20-000015 | |
| us-gaap | UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic | Undistributed Earnings (Loss) Allocated to Participating Securities, Basic | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0000950170-25-047212 |
| us-gaap | UnrealizedGainLossOnDerivatives | Unrealized Gain (Loss) on Derivatives | USD | -1.88M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 |
| us-gaap | UnrealizedGainLossOnInvestments | Unrealized Gain (Loss) on Investments | USD | -40,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 | |
| us-gaap | UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation | Unrecognized Tax Benefits, Decrease Resulting from Foreign Currency Translation | USD | 302,000 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-31 | 0001437749-23-008834 |
| us-gaap | UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities | Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities | USD | 5.36M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-29 | 0001437749-24-010123 |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued | Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-29 | 0001437749-24-010123 | |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions | USD | 125,000 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-13 | 0001583648-20-000015 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromForeignCurrencyTranslation | Unrecognized Tax Benefits, Increase Resulting from Foreign Currency Translation | USD | 103,000 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-31 | 0001583648-21-000005 |
| us-gaap | USGovernmentSecuritiesAtCarryingValue | US Government Securities, at Carrying Value | USD | 5.30M | 2019-12-31 | 2019 | FY | 10-K | 2020-03-13 | 0001583648-20-000015 | |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 12.88M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 |
| us-gaap | VariableLeaseCost | Variable Lease, Cost | USD | 12,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-133372 |
| us-gaap | WeightedAverageNumberDilutedSharesOutstandingAdjustment | Weighted Average Number Diluted Shares Outstanding Adjustment | shares | 0 | 2024-01-01 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-14 | 0001437749-24-026778 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 14.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 56.30M | 2021-01-01 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-17 | 0001583648-21-000023 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 14.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448638 |
| us-gaap | WorkersCompensationLiabilityCurrent | Workers' Compensation Liability, Current | USD | 319,031 | 2013-12-31 | 2014 | FY | 10-K | 2015-03-30 | 0001193125-15-109883 |